attachment 3 to pla-6124 ec-radn-1128, revision i · sses design basis (reference 14), this...

Attachment 3 to PLA-6124

EC-RADN-1128, Revision I

NUCLEAR ENGINEERING CALCULATION COVER SHEET

NEPM-QA-0221-1 1. Page 1 of 86Total Pages 88

-2. TYPE: CALC J3. NUMBER: EC-RADN-1128 -4. REVISION:

*5 UNIT 3 *-6 QUALITY CLASS: Q

;7. DESCRIPTION: Steam Line Break Accident CRHE and Off Site Doses - AST

1

8. SUPERSEDED BY:

9. Alternate Number: 10. Cycle:.

11. Computer Code/Model used: RADTRAD V3.03 12. Discipline: R

-13. Are any results of this calculation described in the Licensing Documents?

Z • Yes, Refer to NDAP-QA-0730 and NDAP-QA-0731 El No

,14. Is this calculation changing any method of evaluation described in the FSAR and using the results to

support or change the FSAR? (Refer to PPL Resource Manual for Definition of FSAR)

• Yes, 50.59 screen or evaluation required. [] No

'15. Is this calculation Prepared by an External Organization?

EYes IlNo

EG771 Qualifications may not be required for individuals from external orgnizations (see Section 7.4.3).

.- 16. Prepared by:

, 17. Reviewed by:

I p18. Verified by:

,-19. Approved by:

,-20. Accepted by:

K. Weise)

Print Name(EG 771 Qualification Requireal , Signature Date

P. L. Bunker .

Print Name(EG771 Qualification Required) Signature Date

P. L. Bunker

Print Name(EG771 Qualification Required) Signature Date

M. M. Waseluse/- e dperNEPM,---02414, •a•n SigtePrint Name(Qualified per NEPM-QA-0241 and v.•2 - Signaturecomply with Section 7.8 of NEPM-QA-0221)

Date

Print Name(EG771 Qualification Required) andcomely with Section 7.9 of NEPM-OA -0221

Signature 0 Date

TO BE COMPLETED BY DCSDCS SIGNATURE/DATE

ADD A NEW COVER PAGE FOR EACH REVISIONFORM NEPM-QA-0221-1, Revision 8, Page 1 of 1, ELECTRONIC FORM

* Verified Fields- REQUIRED FIELDS

Page la

CALCULATION REVISION DESCRIPTION SHEETNEPM-QA-0221-2

REVISION NO: 1 CALCULATION NUMBER: EC-RADN- 1128

SFULL REVISION III SUPERSEDED

FII PAGE FOR PAGE E-- VOIDED

A R RRevised d P m DescriptionPages d 1 v of Revision on the Listed Pages

All D Calculation reprinted in entirety.

la, lb E- D Air intake location on reactor building at Elev. 810'-3".

1,2, 16, 17, 18, 20, Tables 1, 6, 7, & E E 0 Air intake location on reactor building at Elev. 810'-3" with8 corresponding changes in dispersion characteristics and

CRHE doses.

11, Table 3 D 0 E Minor editorial

Attachments 5 & 6 E F 1 RADTRAD output for CRHE doses

__ F-1 __

_ _ _ _ _ l Eli El

_ _ _ _ _ l Eli El

_ _ _ _ _ W El_ _ _ _ _ _ W ElD

_-1 IEl1 EIE-I I-! E-I

__ [El _

_ _ _ _ _ _ lI El E_ _ _ _ _ _ LIDI ___ __ __

DD] r]______ DDD3

FORM NEPM-OA-0221-2. Revision 5, Page I of 1 ELECTRONIC FORM

Page lb

TECHNICAL CHANGE SUMMARY PAGENEPM-QA-0221-5

Calculation Number: EC-RADN-1128 Revision No. 1

This form shall be used to (1) record the Technical Scope of the revision and (2) record the scopeof verification if the calculation was verified. It should not be more than one page. Its purposeis to provide summary information to the reviewer, verifier, approver, and acceptor about thetechnical purpose of the change. For non-technical revisions, state the purpose or reason for therevision.

Scope of Revision: Revision 1 re-calculates the CRHE accident doses for the air intake on thereactor building south wall at Elev 810'-3" near the intersection of column lines U and 37.4. Thecalculation does not credit an elevation difference between the blowout panel release and airintake locations. With zero difference in elevations, the calculated exposures at the intake aremaximized for the steam line break "puff' release. The zero elevation difference is consistentwith Regulatory Guide 1.194 guidance and supports the SSES response to AST RAI #3, datedOctober 18, 2006.

Scope of Verification (If verification applies): Verify changes in design input, assumptions,methodology, arithmetic, computer code input/output, results and conclusions.

NEPM-QA-0221-5, Revision 0 Page 1 of 1 ELECTRONIC FORM

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE Calc. No. EC-RADN- 1128Designed By K Weise and Offsite Doses - AST Sh. No. 2Checked By P. L. Bunker

TABLE OF CONTENTS

1.0 PU R P O SE ................................................................................................... ...................... .................... 32.0 CONCLUSIONS AND RECOMMENDATIONS ............................................................................ 33.0 INPUT and ASSUMPTIONS ....................................................................................................... 43.1 Reactor Core and Coolant Source Parameters .................................................................................... 43.2 Accident Scenario Parameters ......................................................................................................... 53.3 Control Room Habitability Design Parameters .................................................... .................................. 63.4 D ose P aram eters ....................................................................................................................................... 63.5 D ispersion Param eters .................................................................. ........................................................ 64.0 METHOD ................................................................................................... ....... 84 .1 N oble G as A ctivity .................................................................................................................................. 84.2 Iodine Activity in Reactor Coolant .................................................................................................. 94.3 Iodine Activity Released in Steam Line Break .............................................................................. 114.4 Effective Relative Concentration at the CRHE Air Intake ............................................................... 134.5 Puff Expansion and Initial Standard Deviation ............................................................................... 154.6 Calculation of CRHE Relative Concentration x/Q .......................... 154.7 Radiological and Transport Model ................................................................................................... 175.0 R E SU L T S ............................................................................................................................................ 186.0 R E FE R EN C E S ............................................................................................................ ....................... 19Attachment 1 RADTRAD Control File Release Fraction and Timing SLB.rft ............................................ 21Attachment 2 RADTRAD Control File Dose Conversion File SLB_Phase 2.inp ...................................... 23Attachment 3 RADTRAD Control File Inventory File SLB_4mc.nif ........................................................ 27Attachment 4 RADTRAD Control File Inventory File SLBpt2mc.nif .................................................... 31Attachment 5 RADTRAD Output TBMST_500cfm_4mcDE_1 128.out .................................................. 35Attachment 6 RADTRAD Output TBMST_500cfin2ptmcDE_1 128.out ............................................... 61


STEAM LINE BREAK ACCIDENT CRHE and OFFSITE DOSES - AST

1.0 PURPOSE

This calculation documents the design basis evaluation of the Control Room HabitabilityEnvelope (CRHE) and offsite radiological doses at the exclusion area boundary and the lowpopulation zone following a postulated steam line break using the Alternate Source Term (AST)methodology described in USNRC Regulatory Guide 1.183 (Reference 1). The break isassumed to occur in the main steam tunnel and be released to the environment via a turbine orreactor building steam tunnel blowout panel. Reactor water and steam iodine specific activitiesare specified using dose equivalent 1-131 (DE 1-131) based on the TEDE dose conversion. Thedoses are calculated using the RADTRAD computer code (Reference 7).

2.0 CONCLUSIONS AND RECOMMENDATIONS

The offsite dose acceptance criterion for the steam line break is provided in Regulatory Guide1.183, Table 6. The CRHE dose acceptance criterion for the main steam line accident isprovided in 10CFR50.67, Accident Source Term, subsection 10CRF50.67(b)(2)(iii).

The offsite dose acceptance criteria at the exclusion area boundary (EAB) and the lowpopulation zone (LPZ) are 25 Rem TEDE for a steam line break with fuel damage or pre-accident iodine spike and 2.5 Rem TEDE for a steam line break with maximum equilibriumiodine activity. The CRHE dose acceptance criterion is 5 Rem TEDE.

The reported steam line break doses using AST methodology are:

Dose Summary for Steam Line Break Accident

Acceptance Criterion - Offsite

EAB

LPZ

Acceptance Criterion - CRHE

CRHE

Pre-accident Spike4 jtCi/gm DE 1-131,

TEDE, Rem25

2.0

0.12

Maximum EquilibriumIodine Activity

0.2 jtCi/gm DE 1-131,TEDE, Rem

2.5

0.10

0.006

5.0

0.93

'5.00.05

PP&L CALCULATION SHEET

Dept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE Calc. No. EC-RADN-1128Designed By K Weise and Offsite Doses - AST Sh. No. 4Checked By P. L. Bunker

3.0 INPUT and ASSUMPTIONS

.The input data and assumptions used in this analysis are summarized in Table 1.

3.1 Reactor Core and Coolant Source Parameters

1. Core thermal power used for this accident is 4032 MWt (Reference 12). The thermal poweris taken as 102% of the 3952 MWt uprate power. The core thermal power is not directlyused in this analysis since there is no fuel damage postulated for this event. The corepower is used to confirm that the reactor coolant and steam activity concentrations areconservative for extended power uprate conditions.

2. The design basis noble gas source term is 100,000 pCi/s after 30 minutes decay and isshown in Table 2. Short lived isotopes (half lives less than one minute) are excluded due toradiological decay. The concentrations shown have been determined to be conservative forextended power uprate with and without hydrogen water chemistry (Reference 14, AppendixE).

3. A total off gas release rate of 403,000 pCi/sec after 30 minutes delay is used for the noblegas source with a core power of 4032 MWt. The individual noble gas concentrations arethen scaled from the 100,000 pCi/sec rate data in Table 2 by applying a factor of 4.03.

The scaling of the 100,000 pCi/sec is similar to the approach in Regulatory Guide 1.98 foranalyzing postulated failures in off gas systems. Regulatory Guide 1.98 assumes a releaserate of 100 pCi/MWt after 30 minute delay at the steam jet air ejector. For a given fueldesign basis defect fraction, the rate of fission product releases through the defects isproportional to the number of fissions or core power. The observed off gas rate isproportional to the fission product release rate (or alternatively core power) assuming nochange in cladding defects. Hence, the observed off gas rate may be directly scaled fromone power level to another as prescribed in Regulatory Guide 1.98. The same approach isused for setting SSES's main condenser offgas rate in Improved Technical Specification3.5.7 (Reference 19).

4. The main steam flow rate is 1.418E+07 Ibm/h, which corresponds to the flow used toestablish the original GE design basis reactor water and steam activities (Reference 14).Reference 14 shows that the activity concentrations at extended power uprate with theanticipated steam flow (1.654E+07 Ibm/h) are bounded by the original design basisconcentrations. Because the original activity concentrations have been retained for theSSES design basis (Reference 14), this analysis uses the original steam flow rate of1.418E+07 Ibm/h to determine the noble gas activities released to the environs. Theapproach is consistent with the design basis and covers existing and power uprate steamflows.

5. The design basis iodine specific activities are shown in Table 3 for the reactor water andmain steam. The water concentrations are maximized by the use of a 2% steam carryover(corresponding to normal water chemistry operation) while the steam concentrations aremaximized using an 8% steam carryover (corresponding to operation with hydrogen water

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE Calc. No. EC-RADN- 1128Designed By K Weise and Offsite Doses - AST Sh. No. 5Checked By P.L. Bunker

chemistry). This approach bounds normal and hydrogen water chemistry operation(Reference 14).

3.2 Accident Scenario Parameters

1. No fuel damage is postulated for the main steam line break. Therefore, the released activityis based on the maximum coolant activity allowed by Improved Technical Specification 3.4.7(Reference 18). Two activity cases are analyzed consistent with Regulatory Guide 1.183,Appendix D guidance:

1. Iodine activities based on a pre-accident spike with a concentration of 4 pCi/g DE1-131.

2. Iodine activities based on the maximum equilibrium value for full power operationwith a concentration of 0.2 pCi/g DE 1-131.

2. For the design basis accident, the reactor is assumed to be in hot standby prior to the break(Reference 13, Task A.28). This condition maximizes the liquid mass release and henceactivity releases.

3. The mass releases for the design basis (hot standby) cases are (Reference 13, Table A.28-3):

Liquid release 84,840 Ibm

Steam release from flashed liquid 6,480 Ibm

Steam from steam dome 6,650 Ibm

From the above, the total amount of coolant as water exiting the vessel is 91,320 Ibm. Thetotal mass release is 97,970 Ibm.

4. The above mass releases are increased by 20% to provide additional margin. Evaluationsof steam line break masses for other extended power uprate plants determined that theincreases in mass releases were small compared to the pre-uprate main steam line breakmasses while at power.

5. Main steam line valves are assumed to start to close at 0.5 seconds on a high flow signaland are fully closed at 5.5 seconds (Reference 20). The closure time ensures that thesteam, water and, radioactivity releases to the environs are over a relatively short duration.

6. All of the radioactivity in the liquid and steam is assumed to be released instantaneously asa ground level release consistent with Regulatory Guide 1.183, Appendix D. No hold-up ordilution is assumed in the reactor or turbine building steam tunnels.

7. The instantaneous release of all the activity within a short period (less than one minute) ismodeled as a puff release consistent with the guidance in Regulatory Guide 1.194. Thisapproach is reasonable since the MSIVs rapidly isolate the break and all the activity isimmediately assumed to be released into the environment.

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE CaIc. No. EC-RADN- 1128Designed By K Weise and Offsite Doses - AST Sh. No. 6Checked By P. L. Bunker

8. The iodine species released from the main steam line are 95% Csl as aerosol, 4.85% aselemental iodine, and 0.15% as organic iodine in accordance with Regulatory Guide 1.183,Appendix D.

3.3 Control Room Habitability Design Parameters

1. No credit is given for filtration of radioiodine in the CRHE. The control room emergencyoutside air filtration system (CREOAS) does not automatically actuate for this accident.Manual operation is not credited because the accident occurs rapidly with the releasemoving away from the control room within minutes.

2. The CRHE's nominal air intake flow rate is 5810 cfm. This analysis uses 6391 cfm, themaximum value for which the system is in compliance with Technical Specification 5.5.7(Reference 17). The use of the maximum flow rate results in the greatest uptake of activityduring the accident.

3. Unfiltered inleakage is 500 cfm. This amount bounds the leakages and error bands fromthe December 2004 CRHE tracer gas tests. Unfiltered ingress/egress leakage throughdoors of 10 cfm is assumed based on NUREG-0800, chapter 6.4 (Reference 10).

4. The control structure habitability envelope volume is 518,000 cu ft (Reference 16). Thecontrol room with volume of 110,000 ft3 is located within this volume. The CRHE andcontrol room are served by CREOAS.

3.4 Dose Parameters

1. CRHE and offsite breathing rates are 3.5E-04 m3/s. Both rates are consistent withRegulatory Guide 1.183, section 4.1.

2. Control room occupancy is based on a maximum exposed individual. The individual isassumed present in the control room 100% of the time during this short duration accident.The occupancy is consistent with Regulatory Guide 1.183, section 4.2, and NUREG-0800,chapter 6.4.

3. Doses are calculated in terms of the TEDE as required by Regulatory Guide 1.183, section4.1. The dose conversion factors for the CEDE are based on Federal Guidance Report 11and the EDE is based on Federal Guidance Report 12. The dose conversion factors appearin Reference 7, Table 11.4.3.3-2. EDEs for additional nuclides were added and included Kr-83m, Kr-85m, Kr-85, Xe-131m, Xe-133m, Xe-135m and Xe-138. The dose conversionfactors were compiled into a RADTRAD.inp file for SSES's AST analyses and are includedas Attachment 2.

3.5 Dispersion Parameters

1. Offsite x/Q values are 8.3E-04 s/m3 (0 - 2 hr) for the EAB and 4.9E-05 s/m3 <0 - 8 hr) for theLPZ (Reference 15, Tables 2.3-92 and 2.3-105).

2. The CRHE x/Q is based on Regulatory Guide 1.194 methods for instantaneous releaseswith duration less than one minute.


Table ISteam Line Break Analysis Input and Assumptions Summary

Description

Core Thermal Power Level

Noble Gas Design Source Term

Design Offgas Release Rate

Design Reactor Water and Steam

Iodine Specific Activities

Design Main Steam Flow

Iodine Carryover Fraction

Pre-accident Iodine Spike

Maximum Equilibrium Iodine Activity

Radioiodine Chemical Species

Liquid Release

Steam Release from Flashed Liquid

Steam Release from the Steam Dome

MSIV Closure Time

Failed Fuel Resulting From MSLB

Holdup in TB

CRHE Volume

CRHE Isolation and CREOAS Start-up

CRHE Air Intake Flow

CRHE Unfiltered Inleakage

CRHE Ingress/egress Flow

Operator and Offsite Breathing Rates

Operator Occupancy Factors

CRHE x/Q

Offsite x/Q

Value

4032 MWt

Table 2100,000 gtCi/s after 30 minutes

403,000 gCi/s after 30 minutes

Table 3

1,418,000 Ibm/h

8%

4.0 pCi/gm DE 1-131

0.2 gtCi/gm DE 1-131

95% CsI, 4.85% Elemental 12,0.15% Organic I

84,840 Ibm

6,480 Ibm

6,650 Ibm

5.5 seconds

0

None

518,000 ft3

None

6391 cfm (max)

500 cfm

10 cfm

3.5E-04 m3/sec

1.0, 24 hrs0.6, 1-4 days0.4, 4-30 days

Puff: 6.3E-04 s/m3

EAB: 8.3E-04 s/m 3, 0-2 hrLPZ: 4.9E-05 s/m 3, 0-8 hr

Source

Reference 12

Reference 6, Table 11.1-1

See section 3.1, item 3

Reference 6, Table 11.1-2

Reference 6, Appendx B

Reference 6

Reference 18;RG 1.183

Reference 18, RG1.183

RG 1.183

Reference 13, Task A.28





RG 1.183

Reference 16


Reference 17


Reference 6

RG 1.183

Reference 6, RG 1.183

Table 7

Reference 15


4.0 METHOD

The offsite and CRHE doses are calculated using the RADTRAD computer code with the inputand assumptions listed in Table 1. The activity released to the environment is provided onTables 3 and 5. The resulting offsite and CRHE doses are provided in Attachments 5 and 6 forthe cases of 4 pCi/gm DE 1-131 and 0.2 pCi/gm DE 1-131, respectively. A maximumunidentified unfiltered inleakage of 500 cfm plus 10 cfm ingress/egress unfiltered inleakage isused in the analysis.

4.1 Noble Gas Activity

The noble gas activity released to the environment is based on the pre-accident noble gas offgas release rate of 403,000 pCi/sec after 30 minutes delay. The steam's noble gas specificactivity (pCi/g) is determined from the off-gas activity source rate accounting for the 30 minutedelay. The specific activities are then used to determine the noble gas release to theenvironment. The noble gas activity in the reactor water is conservatively taken the same asthe steam activity since some water exiting the break will flash to steam. The activities Ai forthe noble gases are given by:

Ai = 4.03 C (M•s+ Mw) exp (Ai *1800 s)Fs

where -

C = noble gas nuclide source rate, pCi/s

Mr= mass of steam released, Ibm

Mw = mass of liquid released, Ibm

Fs = steam flow rate used to establish noble gas equilibrium concentration, Ibm/h

A1 = decay rate for noble gas nuclide i, s-1

4.03 = multiplier accounting for the maximum noble gas source rate of 362,000 pCi/srelative to the design basis rate of 100,000 pCi/s used to specify the noble gassource rates.

The calculated activities Ai available for release during the accident are shown in Table 2.

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE Calc. No. EC-RADN-1128Designed By K Weise and Offsite Doses - AST Sh. No. 9Checked By P. L. Bunker

Table 2Noble Gas Activity Released from MSLB

Steam mass (dome) M,, IbmLiquid mass M,, Ibm

Steam flow rate Fs, Ibm/h30 minute decay, sConversion - s-Ci/hr-uCi403,000 uCi/s rate factor

IsotopeKr-83mKr-85mKr-85Kr-87Kr-88Kr-89Xe-131mXe-133mXe-133Xe-135mXe-135Xe-137Xe-138

Half Life,sec

6.840E+031.570E+043.383E+084.680E+039.972E+031.896E+021.036E+061.987E+054:553E+059.360E+023.287E+042.298E+028.478E+02

7980109584

1.42E+071800

3.60E-034.03

Source Rate, Ci@T = 30min

uCi/sec2.90E+035.60E+032.OOE+011.50E+041.80E+041.80E+021.50E+012.80E+028.20E+036.90E+032.20E+046.70E+022. 1OE+04

ActivityRelease Ai,

. Ci

4.19E-017.29E-012.4 1E-032.36E+002.45E+001.56E+011.81E-033.39E-029.89E-013. •5E+002.75E+001.84E+011.1 OE+0 1

Notes:1. GE "1971" design activity rates forReference 14, Table 11.1-1.

100,000 uCi/s source rate from

2. Noble gas activties are based on 403,000 uCi/s measured at 30 minutes.3. Activity releases are immediate with no hold up in the core or main steamsystem.

4.2 Iodine Activity in Reactor Coolant

The design basis equilibrium halogen activity concentrations in the reactor water and mainsteam are shown in Table 3.


Table 3Iodine Specific Activities

Isotope1-1311-1321-1331-1341-135

Reactor WaterSpecific Activity

uCi/gm1.30E-021.20E-0 18.90E-022.40E-011.30E-01

Reactor SteamSpecific Activity

uCi/gm3.40E-043.90E-032.40E-039.70E-033.70E-03

Notes:

1. Reference 14, Table 11. 1-22. Values bound normal and hydrogen water chemistryoperation. See Input 3. 1, Item #5.

The iodine activity in the reactor coolant is based on the maximum DE 1-131 activity permittedby the technical specifications. Concentration limits (TSiim) of 0.2 pCi/g and 4.0 pCi/g DE 1-131are considered.

The specific activities CRc-i of DE 1-131 in the reactor coolant are given by:

CRc-i = TSiim * CDB-i * DCFI-131I (CDB-i * DCFi)

where -

TSijm = the technical specification limiting concentrations 0.2 pCi/g and 4.0 pCi/g DE1-131

CDB-i = design basis reactor coolant iodine specific activities in Table 3

DCFi = total effective dose equivalent (TEDE) dose conversion factors for iodineisotopes.

The DCFj are derived from the CEDE (from FGR 11, Reference 8) and EDE (from FGR 12,Reference 9) dose conversion factors. A breathing rate of 3.5E-04 m3/s (Input 3.4, item #1),applicable to control room personnel and workers, is used with the CEDE. The TEDE's DCFjfor the iodine isotopes are given by:

DCFi = DCFcEDE,i * BR + DCF.EDE, i

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:

Date November 9, 2006 Steam Line Break Accident CRHE Calc. No. EC-RADN-1128Designed By K Weise and Offsite Doses - AST Sh. No. 11Checked By P. L. Bunker

Observe that the DCFO are given on a per Bq basis whereas the reactor water and steamconcentrations are specified using pCi. No unit conversions are needed since the DCFj areused only as weighting factors, which dimensionally cancel out in the normalization process.The calculated DCFj and specific activities for the reactor coolant are shown in Table 4:

Table 4Reactor Water Iodine Specific Activities at Technical Specification Limits

DE 1-131 Limit TSlim, uCi/gDE 1-131 Limit TSlim, uCi/g

Breathing Rate, m 3/s

40.2

3.5E-04

Isotope1-1311-1321-1331-1341-135

Design BasisReactor WaterConcentration

CD_i (uCi/gm)1.30E-021.20E-018.90E-022.40E-011.30E-01

(Sv/Bq)8.89E-091.03E-101.58E-093.55E-1 13.32E-10

CEDE EDEDose Conversion Dose Conversion

(Sv/Bq-s/m 3)1.82E-141.12E-132.94E-141.30E-137.98E-14

TEDEDose Conversion

DCFi

(Sv/Bq-s/m 3)3.13E-121.48E-135.82E-131.42E-131.96E-13

Concentration@ 4 uCi/gm

DE 1-131

Ci (uCi/gm)0.968.846.5617.689.58

Concentration@ 0.2 uCi/gm

DE 1-131

Ci (uCi/gm)0.0480.4420.3280.8840.479

Notes:1. Design reactor water specific activities from Table 3.2. CEDE h Effective from FGR 11 and EDE h E from FGR 12.

4.3 Iodine Activity Released in Steam Line Break

The iodine releases are based on the reactor coolant activity, carryover to steam, and thecoolant and steam masses released from the break. Coolant concentrations are set by theallowable activity limits in accordance with the technical specifications.

The iodine activity Ai released from the steam line break for a coolant to steam carryoverfraction of 0.08 is

Ai = CRC-i * (Mw + 0.08*Ms)

where -

CRC-i = iodine specific activity of the reactor coolant

Mw= mass of liquid released from the reactor, Ibm

Ms= mass of steam released from the reactor dome, Ibm

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE Calc. No. EC-RADN-1 128Designed By K Weise and Offsite Doses - AST Sh. No. 12Checked By P. L. Bunker

The calculated iodine activity released is summarized in Table 5. Observe that the 8%carryover to the steam results in much greater concentrations than the steam's design basisactivities in Table 3. Because of the large water inventory exiting the break at hot standby, theiodine available for release to the environment is dominated by the reactor waterconcentrations as shown in Table 5.

Table 5Iodine Released from Steam Line Break

Steam mass (dome) M,, Ibm

Liquid mass M,, IbmCarryover to steam fractionConversion, gm-Ci/(lbm-uCi)

7980

1095840.08

4.54E-04

Iodine Activity Release with Reactor Coolant at 4 uCi/am DE 1-131

Isotope1-1311-1321-1331-1341-135

DE 1-131RC Concentration,

uCi/gm0.968.846.5617.689.58

SteamConcentration,

uCi/gm0.080.710.521.410.77

Iodine ActivityRelease,

Ci4.79E+014.42E+023.28E+028.85E+024.79E+02

Iodine Activity Release with Reactor Coolant at 0.2 uCi/gm DE 1-131

Isotope1-1311-1321-1331-1341-135

DE 1-131RC Concentration,

uCi/gm0.0480.4420.3280.8840.479

SteamConcentration,

uCi/gm0.000.040.030.070.04

Iodine ActivityRelease,

Ci2.40E+002.2 1E+011.64E+014.42E+012.40E+0 1

Notes:1. DE 1-131 specific activities from Table 4.2. Steam concentration is based on DE 1- 131 concentration with 8%carryover.3. Steam and liquid masses include 20% margin.

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE Caic. No. EC-RADN-1128Designed By K Weise and Offsite Doses - AST Sh. No. 13Checked By P. L. Bunker

4.4 Effective Relative Concentration at the CRHE Air Intake

The main steam line break is a double ended break in the steam tunnel. The release of steamand activity occurs over a very short time until closure of the MSIVs. The MSIV signal plusclosing time is 5.5 seconds. All the activity is assumed released to the atmosphereinstantaneously as a ground level release without holdup or dilution in the steam tunnel. Theduration is short enough (less than one minute) to consider the release as an instantaneouspuff release in accordance with Regulatory Guide 1.194.

SSES does not have an automatic CRHE intake isolation or start-up of the CREOAS for a mainsteam line break. CRHE intake flow is taken as the normal service flow. No credit is taken forisolation of the CRHE intake or filtration of the radioiodine, especially in view of the shortduration of the exposure. Therefore, calculations of the CRHE X/Qs are amenable to theclosed form solution given below. If CRHE isolation or filtration occurs, then numerical methodswould be required to determine appropriate X/Qs.

The concentration X (x, u, t) for a puff ground level release with the center of the puff passingdirectly over the intake air location is

X(x, u, h, t) = 2 Q * exp {-0.5(x - ut)2 + -0.5 h2 }(2Tr)3/2 (Crz2 + 02)1/2 (ox2 + 0v2) (Ox2 + uv2) (Oz2 + Yv2)

where -

Q activity release, Ci

x = release point to receptor (air intake) distance, m

u - windspeed, m/s

h = difference in elevation between release point and control room intake, m

=x- standard deviation of the puff in the horizontal along the wind direction andcross-wind direction at the CRHE intake location, m

uz = standard deviation of the vertical cross wind direction at the intake location, m

cv = initial standard deviation of the volumetric expansion of the puff, m

The above diffusion equation follows from Reference 5, Eq 10 and Reference 10, Eq 3.154.The units of X(x, u, h, t) are Ci/m 3.

The total exposure during passage of the puff is obtained by integrating over the time of thepuff's passage. The total exposure XT is

XT = f X(X, u, h, t) dt for 0 < t < T


Regulatory Guide 1.194 advises that the integration be carried out to the time T that it takes thetrailing edge to pass the CRHE intake.

The puff is a Gaussian distribution. The exposure time is typically the time that it takes about99.8% of the puff distribution to pass beyond the horizontal distance x0 to the air intake.Approximately 99.8% of the distribution passes the intake when the center of puff travelsdownwind of the intake by a distance of three standard deviations in the horizontal direction.The time T at which the puff has passed the intake is then given by:

T = x + 3 (0x2 + Y2j/

uwhere -

x0 = horizontal distance in x direction to intake location, m

u = windspeed, m/s

ax = standard deviation of the puff in the horizontal along the wind direction at theCRHE control intake location, m

a= initial standard deviation of the volumetric expansion of the puff, m

A simplification is made by considering the entire tail of the puff. The above equation for XT isintegrated over all time (i.e., T -o ) instead of up to T1. The total exposure XT then followsdirectly from Reference 10, Eq 3.158 in that

X(x, u, h) = Q *exp{ -0.5h 2 }(01 + av2)Tr u (cy, 2 + cv2) 1/2 (ic),2 + T21/

Thus, the equation has the same form as the equation for a continuous plum concentration.For example, the above equation can be compared to Reference 10, Eq 3.116 or Reference 4,Eq 1. Observe that oz and ax are functions of the distance x to the intake.

The x/Q for the duration of the puff passage T is then taken as

X/Q = X(x, u, h)/Q

where Q and X(x, u, h) are defined above.

1 The difference in exposures is negligible since 99.8% of the puff's distribution is considered. The

specification of T, however, is beneficial since it can provide insight into the air intake exposuretime.


4.5 Puff Expansion and Initial Standard Deviation

The activity released from the steam line break is assumed uniformly distributed in a puffvolume expanded to atmospheric pressure. The size of the puff is set by the fluid massreleased during the steam line break.

The volume V of the puff is

V = (MS +Mw) *Vsp

where -

Ms = mass of steam released, Ibm

Mw= mass of liquid released, Ibm/s

Vsp= specific volume of saturated steam at 14.7 psia, 26.8 ft3/lbm

The standard deviation of the puff av is obtained by setting the initial ground level concentrationX(O, u, 0, 0) equal to the puff's concentration after expansion, QN. The resulting equation is(Reference 5, p. 19):

=Y 2 V " 1/3

where V is the initial volume of the puff after expansion.

In determining the volume, the entire mass of fluid from the break is used consistent with theassumption of instantaneously releasing the entire inventory of noble gas and iodine. Themasses from section 3.2, items #3 and #4, are used to maximize the release of water andhence available radioiodine. At power, a greater amount of steam and flashing can beexpected than in hot standby. Therefore, the use of entire fluid inventory is reasonable.Calculated results are shown in Table 6.

4.6 Calculation of CRHE Relative Concentration xlQ

The CRHE x/Qs associated with a release from each blowout panel are calculated and shownin Tables 6 and 7. x/Qs are calculated in accordance with Sections 4.4 and 4.5 above.

Table 6 identifies the main steam blowout panel locations, elevations, horizontal distances toCRHE air intake, and relative heights to the intake. The normal standard deviations ax and azof the puff are functions of horizontal distance to the intake and are also shown. These valuesare determined from Regulatory Guide 1.194, Figures 4 and 5.


Table 6MST Blowout Panel Locations, Distances and Dispersion Coefficients

Elevation, Distance, Aheight, sigmax, -sigma z,Release Point .ft m m m Im

RB Unit 2 Air Intake 810.3 n/a n/a n/a n/aTB Unit 1MST blowout panel 717.5 115 28 5.2 2.5TB Unit 2 MST blowout panel 717.5 41 28 2.1 1.1RB Unit 1 MST blowout panel 802.5 88 2 4.1 2.0RB Unit 2 MST blowout panel 802.5 52 2 2.6 1.3

Notes:1. Aheight is the difference between intake and blowout panel elevations.2. sigmax and sigma z are from Reg Guide 1.194, Figures 4 and 5, for class F stability.3. Reference drawings:

E-105004, Sh. 3; E-105004, Sh. 6; E-105618; E-105670; E296155, Shs. l and 3.

Several release masses are shown in Table 7 to ensure a bounding exposure is used todetermine doses at the CRHE. The time integrated exposures X(x, u, h) at the CRHE inlet arecalculated using the equation developed in Section 4.4 with the distances tabulated in Table 6.The exposures were determined for a wind speed of 1 m/s with class F stability. The differencein elevation between intake and release locations (shown in Table 6 for information) is taken aszero in Table 7. This practice essentially maximizes the exposure at the air intake2 .

Table 7 shows that the maximum exposures at the CRHE air intake occur for the case (d) massrelease. The corresponding x/Q value for use in the dose calculation is

x/Q 73.8 Ibm-s/mi3 /(117,654 Ibm) = 6.3E-04 s/m 3

Table 7 also shows the maximum X/Qs for cases (a) to (c). In general, these cases havegreater X/Qs than case (d); however, the exposures (which also consider the size of the steamreleases) are less. Case (d) will yield the greatest CRHE doses since the combined activity (ormass) and dispersion gives the largest exposures. Case (d) will also give the largest offsitedoses for continuous releases assumed for the EAB and LPZ analyses.

Inspection of Table 7 reveals that dispersion is dominated by the initial expansion of the puffrather than the normal dispersion. The dispersion is relatively insensitive to horizontal distancefor each release case because the puff's radius is smaller than the distance to the intake. After

2 The exposure is maximized because the puff equations in Section 4.4 and RG 1.194 are for

neutrally buoyant gases. The exposure is maximized when the source and receiver are at thesame elevation. Steam puffs are buoyant. The concentrations at the receiver location are typicallyless than the neutrally buoyant releases near the source because the center of the puff has movedabove the receiver elevation as it passes by.

PP&L CALCULATION SHEET

Dept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE CaIc. No. EC-RADN-1 128

Designed By K Weise and Offsite Doses - AST Sh. No. 17Checked By P. L. Bunker

initial expansion, the exposure at the intake is due to the entire puff as it travels by. The timesT for the puff releases to have moved beyond the intake are also shown. Three minutes is atypical exposure duration.

Table 7CRHE Effective X/Qs For Steam Line Breaks

Windspeed, m/sVapor sp. volume, f13/lbmAheight, m

1.026.8

0

Puff Mass and Expansion(a) (b) (c)

13,130 35,000 97,970(d)

117,564Puff mass, Ibm3Volume, m

Sigmapuff, m

Release PointTB Unit 1 MST blowout panelTB Unit 2 MST blowout panelRB Unit I MST blowout panelRB Unit 2 MST blowout panel

Maximum Effective x/Qs, s/m 3

Time T, s

9,964 26,561 74,349 89,21810.8 15.0 21.1 22.5

Exnosure v(x. I m/s. 0 m). ibm-s/m 3

31.434.932.934.5

46.249.047.448.7

67.469.468.369.2

71.973.872.773.6

2.7E-03 1.4E-03 7.1E-04 6.3E-04151 163 180 184

Notes:1. Puff masses based on the following:

(a) steam mass release at hot standby,(b) steam plus flashed liquid similar to FSAR Table 3.6A MST analysis,(c) total steam plus liquid mass release at hot standby,(d) 20% margin added to case (c).

2. X /Qs are for ground level release and intake ( Ah = 0 m).3. T is the time for >99.8% of the puff to pass the intake for each case.

4.7 Radiological and Transport Model

RADTRAD 3.03 is used for the dose models and calculations. The model consists of steam tunnel,CRHE and environment nodes with four interconnecting pathways.

All the steam activity from the line break is released in 5.5 seconds into the tunnel. The activity ispurged from the tunnel to the environment within seconds using an arbitrarily high flow ratepathway. Offsite and CRHE doses are calculated using the parameters described in sections 3.3,3.4 and 3.5.

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE Calc. No. EC-RADN- 1128Designed By K Weise • and Offsite Doses - AST Sh. No. 18Checked By P. L. Bunker

The CRHE dose calculation uses case (d)'s worst case x/Q from Table 7 with the activities fromTables 2 and 5 corresponding to a hot standby mass release (with 20% margin). The total CRHEunfiltered inleakage is 510 cfm. The air intake is 6391 cfm throughout the accident with CREOASnot credited.

Nuclide release and dose conversion factor files are shown in Attachments 1 and 2. Nuclideinventories are developed from Tables 3 and 5. Two files corresponding to the 4 pCi/gm and 0.2pCi/gm DE 1-131 cases are shown in Attachments 3 and 4, respectively. The physical and flowmodels are shown as part of the RADTRAD input in Attachments 5 and 6.

5.0 RESULTS

The reported offsite and CRHE doses based on the results of the RADTRAD calculations are listedin Table 8.

Table 8Offsite and CRHE Dose Results - Steam Line Break

Pre-existing Iodine Spike4 pCi/gm DE 1-131

TEDE, Rem

Acceptance Criterion - Offsite

EAB

LPZ

Acceptance Criterion - CRHE

CRHE

25

2.0

0.12

5.0

0.93

Maximum EquilibriumActivity

0.2 pCi/gm DE 1-131TEDE, Rem

2.5

0.100.006

5.00.05 INotes:

1. RADTRAD output files are in Attachments 5 and 6.2. CRHE dose includes 30 day exposure in building after puff passage.

The EDE doses included in the TEDE are based on the CRHE volume of 518,000 ft3 used inRADTRAD. No additional finite cloud reduction for the actual control room volume of 110,000 ft3 isapplied since the EDE contribution is an insignificant contributor to the reported CRHE TEDE dose.


6.0 REFERENCES

1. USNRC Regulatory Guide 1.183, "Alternative Radiological Source Terms For EvaluatingDesign Basis Accidents At Nuclear Power Reactors", July 2000.

2. USNRC Regulatory Guide 1.5, "Assumptions Used For Evaluating the Potential RadiologicalConsequences of a Steam Line Break Accident for Boiling Water Reactors", 3/71.

3. USNRC Regulatory Guide 1.98, "Assumptions Used For Evaluating The PotentialRadiological Consequences Of A Radioactive Offgas System Failure In A Boiling WaterReactor", March 1976.

4. USNRC Regulatory Guide 1.145, "Atmospheric Dispersion Models for Potential AccidentConsequence Assessments at Nuclear Power Plants", February 1983.

5. USNRC Regulatory Guide 1.194, "Atmospheric Relative Concentrations for Control RoomRadiological Habitability Assessments at Nuclear Power Plants", June 2003.

6. NUREG-0800, USNRC Standard Review Plan Section 6.4, Control Room HabitabilitySystem, Revision 2.

7. NUREG/CR-6604, RADTRAD: A Simplified Model for RADionuclide Transport and RemovalAnd Dose Estimation, and Supplement 1, 6/8/99.

8. Federal Guidance Report No. 11, "Limiting Values of Radionuclide Intake and AirConcentration and Dose Conversion Factors for Inhalation, Submersion, and Ingestion",1988.

9. Federal Guidance Report No. 12, "External Exposures to Radionuclides in Air; Water; andSoil Based on the 1987 Federal Radiation Protection Guidance", 1993.

10. USAEC, Meteorology and Atomic Energy 1968.11 .ASME Steam Properties for Industrial Use, Version 1.0.1.

12. EPUMELLLA+ Design Input Request T0200Core Design, Rev. 0.13. PPL Calculation EC-PUPC-1001, NEDC-32161 P, General Electric Power Uprate

Engineering Report For Susquehanna Steam Electric Station, Revision 6, 5/24/04.14. PPL Calculation EC-RADN-1 038, Radioactive Material Source Term Evaluation for Normal

Conditions with Hydrogen Water Chemistry, Revision 1.15. PPL Calculation EC-ENVR-1 057, Offsite X/Q Values for SSES Based on 1999 - 2003

Meteorological Data, Revision 0, April 4, 2005.16. PPL Calculation EC-030-502, Control Structure Bldg. Volume, Revision 0, 12/17/93.17. SSES Improved Technical Specification 5.5.7, "Ventilation Filter Testing Program",

Amendments 178 and 186.

18. SSES Improved Technical Specification 3.4.7, "Reactor Coolant System, Specific Activity";Amendments 178 and 195. Bases for Improved Technical Specifications B 3.4.7.

19. SSES Improved Technical Specification 3.7.5, "Main Condenser Off Gas", Amendments 151and 178. Bases for Improved Specification B 37.5.

PP&L CALCULATION SHEETDept. 0341 Rad & Eff Tech PROJECT:Date November 9, 2006 Steam Line Break Accident CRHE Calc. No. EC-RADN-1 128.Designed By K Weise and Offsite Doses - AST Sh. No. 20Checked By P. L. Bunker

20. SSES Improved Technical Specification 3.6.1.3, "Primary Containment Valves (PCIVs)", SR3.6.1.3.7, Amendments 193 and 168.

21. Reference SSES Drawings:E-105004, Sh. 3, Rev 26.-E-105004, Sh. 6, Rev 22.E-105618, Rev 1.

E-105670, Rev 8.E-296155, Sh. 1, 10/26/2006.

E-296155, Sh. 3, 10/26/2006.

EC-RADN-1 128 Attachment 1 Page 21

Attachment 1 RADTRAD Control File Release Fraction and Timing SLB.rft


Release Fraction and Timing Name: SSES MSLB - Release Break Activity In 5.5 SecsSourcesDuration (h): Design Basis Accident

0. 1528E-06Noble Gases:1.fOOOE+00

Iodine:1.OOOOE+00

Cesium:o.OOOOE+00

Tellurium:o.OOOOE+00

Strontium:o.OOOOE+00

Barium:o.OOOOE+00

Ruthenium:o.OOOOE+00

Cerium:o.OOOOE+00

Lanthanum:o.OOOOE+00

O.OOOOE+00 O.OOOOE+00 0.0000E+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

0o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

0.0000E+00

0.OOOOE+00

o.OOOOE+00

o.OOOOE+00

o.OOOOE+00

0.OOOOE+00

o.OOOOE+00

0.OOOOE+00

0.OOOOE+00Non-Radioactive Aerosols (kg):O.OOOOE+00 O.OOOOE+0O 0.OOOOE+00 O.OOOOE+00

End of Release File

EC-RADN-l 128 Attachment 2 Page 23

Attachment 2 RADTRAD Control File Dose Conversion File SLBPhase 2.inp


FGR11&12 edited+TID 30.inp Kr83m Xel31m 133m 135mImplicit daughter halflives (m) less than 90 and

9 ORGANS DEFINED IN THIS FILE: ICRP-30

138 beta-test version 1.10less than 0.100 of parent

GONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN(FGR)

1E1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83mKr-85mKr-87Kr-88Kr-85Xe-138

1-131GONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN(FGR)1-132GONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN(FGR)1-133GONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN (FGR)1-134GONADSBREASTLUNGSRED MARR

NUCLIDES DEFINED IN THIS FILE:DDDDD Including:Xe-135m

CLOUDSHINE

1.780E-142.040E-141.760E-141.680E-143.450E-1411.810E-141.670E-141.820E-142.980E-14

1.090E-131.240E-131.090E-131.070E-131.730E-131.120E-131.050E-131.120E-131.580E-13

2.870E-143.280E-142.860E-142.770E-144.870E-142.930E-142.730E-142.940E-145.830E-14

1.270E-131.440E-131.270E-131.250E-13

.GROUND GROUND GROUND INHALEDSHINE 8HR SHINE .7DAY SHINE RATE ACUTE

1.119E-111 .082E-111 .016E-111 .022E-111 .675E-111. 053E-119. 908E-121. 067E-111 .825E-11

2 .523E-112 .414E-I12. 305E-112 .360E-113 .327E-112 .381E-112.283E-112.403E-118.199E-11

1 .585E-111 .519E-111 .446E-111 .466E-112. 161E-111. 502E-111 .418E-111 .509E-111 .150E-10

1.200E-111. 145E-111.100E-II1. 127E-11

1. 789E-101.730E-101.626E-101. 635E-102.679E-101.685E-101.585E-101.707E-102. 920E-10

2.771E-112.652E-112.532E-112.592E-113.655E-112.616E-112.509E-112.640E-119. 007E-11

6. 748E-116.468E-1l6.156E-116.242E-119.202E-116.393E-116.038E-116.425E-114. 897E-10

1.202E-111. 147E-111. 102E-111. 129E-11

3.940E-16-1.OOOE+003.810E-16-1.000E+003.580E-16-1.OOOE+003.600E-16-1.000E+005.900E-16-1.000E+003.710E-16-1.000E+003.490E-16-1.000E+003.760E-16-1.OOOE+006.430E-16-1.000E+00

2.320E-15-1.000E+002.220E-15-1.000E+002.120E-15-1.000E+002.170E-15-1.000E+003.060E-15-1.000E+002.190E-15-1.000E+002.100E-15-1.OOOE+002.210E-15-1.000E+007.540E-15-1.OOOE+00

6.270E-16-1.OOOE+006.010E-16-1.OOOE+005.720E-16-1.OOOE+005.800E-16-1.000E+008.550E-16-1.000E+005.940E-16-1.OOOE+005.610E-16-1.OOOE+005.970E-16-1.000E+004.550E-15-1.OOOE+00

2.640E-15-1.OOOE+002.520E-15-1.OOOE+002.420E-15-1.OOOE+002.480E-15-1.000E+00

INHALEDCHRONIC

2.530E-117.880E-116.570E-106.260E-115.730E-112.920E-078.030E-118.890E-090.000E+00

9.950E-121.410E-112.710E-101.400E-111.240E-111.740E-093.780E-111.030E-100.OOOE+00

1.950E-112.940E-118.200E-102.720E-112.520E-114.860E-085.OOOE-1I1.580E-090.OOOE+00

4.250E-126.170E-121.430E-106.080E-12

INGESTION

4.070E-111.210E-101.020E-109.440E-118.720E-114.760E-071.570E-101.440E-080.OOOE+00

2.330E-112.520E-112.640E-112.460E-112.190E-113.870E-091.650E-101.820E-100.OOOE+00

3.630E-114.680E-114.530E-114.300E-114.070E-119.100E-081.550E-102.800E-090.OOOE+00

1.100E-111.170E-111.260E-111.090E-11

EC-RADN-1 128

BONE SURTHYROIDREMAINDEREFFECTIVESKIN (FGR)1-135GONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN(FGR)Xe-131mGONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN (FGR)Xe-133mGONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN (FGR)Xe-133GONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN(FGR)Xe-135mGONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVE'SKIN (FGR)Xe-135GONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN (FGR)Kr-83m

1 ;960E-131.300E-131.220E-131.300E-131. 870E-13

8.078E-149. 143E-148.145E-148.054E-141. 184E- 138.324E-147. 861E-148.294E-141.156E-13

4.570E-166 .020E-162. 670E- 162 .270E-161.060E-153. 910E-162 .710E 1 163 .378E-16

4. 820E-15

1. 420E-151. 700E-151. 190E-151. 100E-153 .230E-151. 360E-151. 150E-151.370E-151.040E-14

•1. 610E-151. 960E-151.320E-151. 070E-155. 130E-151.510E-151.240E-151. 560E-154. 970E-15

2 . OOOE-142.290E-141. 980E-141. 910E-143. 500E-142. 040E-141.890E-142.040E-142. 970E-14

1.170E-141.330E-141.130E-141.070E-142.570E-141.180E-141.080E-141.190E-14

3.12OE-14

1.568E-11-1.127E-111.091E-111.150E-114 .477E-11

.3.113E-112.971E-112.886E-112. 965E-113.983E-112. 852E-112.883E-112. 989E-119.826E-11

7. 872E-138.471E-133.565E-132. 792E-131.677E-125.220E-133. 993E-135.876E-131.266E-12

1.337E-121.383E-128.609E-137. 844E-132.599E-121. 028E-128.855E-131. 112E- 121. 894E-12

1.465E-121.505E-121. 045E-128. 791E-134 .254E-121. 181E-121. 042E-121. 299E-121. 953E-12

5. 929E-135.691E-135.347E-135 .400E-138.246E-135.612E-135 .241E-135.612E-131.866E-12

5 .455E-125. 325E-124. 959E-124. 959E-129. 120E-125 .023E-124 .829E-125 .217E-124 .506E-11

1.571E-111.129E-111.093E-111.152E-114.485E-11

5.489E-115.240E-115..089E-115 .228E-117 .024E-115. 030E-115 .084E-115 .271E-111. 733E-10

1.371E-111 .475E-116 .209E-124. 863E-122. 920E-119. 089E-126. 954E-121. 023E-112 .205E-11

1.188E-111.230E-117.656E-126. 975E-122.311E-119. 138E-127. 874E-129. 892E-121.684E-11

2. 052E-112. 107E-111 .464E-111. 231E-115. 958E-111 .653E-111 .460E-111 .819E-112 .734E-11

5. 929E-135 .691E-135. 347E-135 .400E-138 .246E-135. 612E-135 .241E-135. 612E-131. 866E-12

1.194E-111. 166E-111.086E-111.086E-111.997E-111.100E-111.058E-111.142E-119.867E-11

Attachment 2

3.450E-15-1.OOOE+002.480E-15-1.OOOE+0o2.400E-15-1.OOOE+002.530E-15-1.000E+009.8'50E-15-1.000E+00

1.599E-15-1.OOE+001.526E-15-1.000E+001.482E-15-1.OOOE+001.523E-15-1.OOOE+002.046E-15-1.OOOE+001.465E-15-1.OOOE+001.481E-15-1.OOOE+001.535E-15-1.OOOE+005.047E-15-1.OOOE+00

2.760E-17-1.OOOE+002.970E-17-1.OOOE+001.250E-17-1.000E+009.790E-18-1.OOOE+005.880E-17-1OOOE+001.830E-17-1.OOOE+001.400E-17-1.OOOE+002.060E-17-1.OOOE+004.440E-17-1.OOOE+00

4.890E-17-1.OOOE+005.060E-17-1.OOOE+003.150E-17-1.OOOE+002.870E-17-1.OOOE+009.510E-17-1.OOOE+003.760E-17-1.OOOE+003.240E-17-1.OOOE+004.070E-17-1.OOOE+006.930E-17-1.OOOE+00

5.200E-17-1.OOOE+005.340E-17-1.OOOE+003.710E-17-1.OOOE+003.120E-17-1.000E+001.510E-16-1.OOOE+004.190E-17-1.OOOE+003.700E-17-1.000E+004.610E-17-1.OOOE+006.930E-17-1.OOOE+00

4.480E-16-1.OOOE+004.300E-16-1.OOOE+004.040E-16-1.OOOE+004.080E-16-1.OOOE+006.230E-16-1.OOOE+004.240E-16-1.OOOE+003.960E-16-1.00OE+004.240E-16-1.OOOE+001.410E-15-1.OOOE+00

2.530E-16-1.OOOE+002.470E-16-1.000E+002.300E-16-1.OOOE+002.300E-16-1.OOOE+004.230E-16-1.000E+002.330E-16-1.OOOE+002.240E-16-1.OOOE+002.420E-16-1.OOOE+002.090E-15-1.OOOE+00

Page 25

5.310E-122.880E-102.270E-113.550E-11O.OOOE+00

1. 700E-112.340E-114.410E-102.240E-112.01OE-118.460E-094. 700E-113.320E-10o.OOOE+00

o.OOOE+00o.OOOE+000. OOOE+000. OOOE+000. OOOE+00o.OOOE+000 . OOOE+000. OOOE+000 . OOOE+00

0. OOOE+000. OOOE+000. OOOE+00o.OOOE+000. OOOE+000 . OOOE+000. OOOE+000. OOOE+000 . OOOE+00

o.OOOE+00o.OOOE+000 . OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00

o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00

o.OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+00o.OOOE+000. OOOE+000. OOOE+00

9. 320E-126.210E-101.340E-106.660E-11o.O0OE+00

3 .610E-113.850E-113. 750E-113.650E-113.360E-111.790E-081.540E-106.080E-10o.OOOE+00

o.000E+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+000. OOOE+000. OOOE+000. OOOE+00

0. OOOE+000.OOOE+000. OOOE+000. OOOE+000. 000E+000 . OOOE+000. OOOE+000. OOOE+00o.OOOE+00

0. OOOE+00o.OOOE+00o.OOOE+000. OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.000E+00

o.OOOE+00o.OOOE+00O0000E+O0o.OOOE+000. 000E+000. OOOE+000. OOOE+000. OOOE+00o..OOOE+00

0. OOOE+00o.OOOE+000 . OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+00o.OOOE+000 . OOOE+00


GONADS 1.710E-18 5.572E-15 5.855E-15 6.160E-19-1.OOOE+00 O.OOOE+00 O.OOOE+00BREAST 5.050E-18 9.498E-15 9.980E-15 1.050E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00LUNGS 1.640E-19 1.266E-16 1.331E-16 1.400E-20-1.OOOE+00 O.OOOE+00 O.OOE+00RED MARR 3.830E-19 5.617E-16 5.902E-16 6.210E-20-1.OOOE+00 0.OOOE+00 O.OQOE+00BONE SUR 2.250E-18 3.437E-15 3.612E-15 3.800E-19-1.000E+00 O.OOOE+00 O.OOOE+00THYROID 6.430E-19 7.698E-16 8.088E-16 8.510E-20-1.OOOE+00 O.OOOE+00 O.OOOE+00REMAINDER 5.300E-19 1.393E-15 1.464E-15 1.540E-19-1.OOOE+00 O.OOQE+00 O.OOOE+00EFFECTIVE 1.500E-18 3.437E-15 3.612E-15 3.800E-19-1.OOOE+00 O.OOOE+00 O.OOOE+00SKIN(FGR) 3.560E-17 1.167E-13 1.226E-13 1.290E-17-1.OOOE+00 O.OOOE+00 O.OOOE+00Kr-85mGONADS 7.310E-15 2.594E-12 3.653E-12 1.570E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00BREAST 8.410E-15 2.527E-12 3.560E-12 1.530E-16-1.OOOE+00 0.OOOE+00 O.OOOE+00LUNGS 7.040E-15 2.379E-12 3.351E-12 1.440E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00RED MARR 6.430E-15 2.346E-12 3.304E-12 1.420E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00BONE SUR 1.880E-14 5.286E-12 7.446E-12 3.200E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00THYROID 7.330E-15 2.395E-12 3.374E-12 1.450E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00REMAINDER 6.640E-15 2.313E-12 3.257E-12 1.400E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00EFFECTIVE 7.480E-15 2.511E-12 3.537E-12 1.520E-16-1.OOOE+Oo 0.OOOE+00 O.OOOE+00SKIN(FGR) 2.240E-14 2.247E-11 3.164E-11 1.360E-15-1.000E+00 O.OOOE+00 O.OOOE+00Kr-87GONADS 4.OOOE-14 4.962E-12 5.026E-12 7.610E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00BREAST 4.500E-14 4.740E-12 4.802E-12 7.270E-16-1.OOOE+00 O.OOE+00 O.OOOE+00LUNGS 4.040E-14 4.603E-12 4.663E-12 7.060E-16-1.O0OE+00 O.OOOE+00 O.OOOE+00RED MARR 4.OOOE-14 4.708E-12 4.769E-12 7.220E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00BONE SUR 6.020E-14 6.514E-12 6.598E-12 9.990E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00THYROID 4.130E-14 4.473E-12 4.531E-12 6.860E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00REMAINDER 3.910E-14 4.590E-12 4.650E-12 7.040E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00EFFECTIVE 4.120E-14 4.773E-12 4.835E-12 7.320E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00SKIN(FGR) 1.370E-13 8.802E-11 8.916E-11 1.350E-14-1.OOOE+00 O.OOOE+00 O.OOOE+00Kr-88GONADS 9.900E-14 2.278E-11 2.655E-11 1.800E-15-1.000E+00 O.OOOE+00 O.OOOE+00BREAST 1.110E-13 2.177E-11 2.537E-11 1.720E-15-1.OOOE+00 0.000E+oo O.OOOE+00LUNGS 1.010E-13 2.139E-11 2.493E-1I 1.690E-15-1.OOOE+00 0.000E+00 O.OOOE+00RED MARR 1.OOOE-13 2.190E-11 2.552E-1I 1.730E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00BONE SUR 1.390E-13 2.886E-11 3.363E-11 2.280E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00THYROID 1.030E-13 2.012E-11 2.345E-11 1.590E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00REMAINDER 9.790E-14 2.139E-11 2.493E-11 1.690E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00EFFECTIVE 1.020E-13 2.202E-11 2.567E-11 1.740E-15-1.OOOE+00 O.OQOE+00 O.OOOE+00SKIN(FGR) 1.350E-13 5.607E-11 6.534E-11 4.430E-15-1.OOOE+00 O.OOOE+00 O.OOE+00Kr-85GONADS 1.170E-16 8.121E-14 1.704E-12 2.820E-18-1.OOOE+00 O.OOOE+00 O.OOE+00BREAST 1.340E-16 7.891E-14 1.656E-12 2.740E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00LUNGS 1.140E-16 7.056E-14 1.481E-12 2.450E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00RED MARR 1.090E-16 6.998E-14 1.469E-12 2.430E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00BONE SUR 2.200E-16 1.287E-13 2.702E-12 4.470E-18-1.OOOE+00 O.OOE+00 O.OOOE+00THYROID 1.180E-16 7.459E-14 1'565E-12 2.590E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00REMAINDER 1.090E-16 6.941E-14 1.457E-12 2.410E-18-1.OOOE+00 O.OOOE+00 O.OOOE+00EFFECTIVE .1.190E-16 7.603E-14 1.596E-12 2.640E-18-1.OOOE+00 O.OOOE+00 0.000E+00SKIN(FGR) 1.320E-14 2.304E-11 4.835E-10 8.000E-16-1.000E+00 O.OOE+00 O.OOE+00xe-138GONADS 5.590E-14 O.OOOE-14 O.OOOE-12 1.070E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00BREAST 6.320E-14 O.OOOE-14 0.OOOE-12 1.020E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00LUNGS 5.660E-14 O.OOOE-14 0.OOOE-12 9.970E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00RED MARR 5.600E-14 O.OOOE-14 0.OOOE-12 1.020E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00BONE SUR 8.460E-14 O.OOOE-13 0.OOOE-12 1.410E-15-1.OOOE+00 O.OOOE+00 O.OQOE+00THYROID 5.770E-14 O.OOOE-14 O.OOOE-12 9.550E-16-1.OOOE+00 0.000E+00 O.OOOE+00REMAINDER 5.490E-14 O.OOOE-14 O.OOOE-12 9.940E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00EFFECTIVE 5.770E-14 O.OOOE-14 O.OOOE-12 1.030E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00SKIN(FGR) 1.070E-13 O.OOOE-11 O.OOOE-10 7.650E-15-1.OOOE+00 O.OQOE+00 O.OOOE+00

EC-RADN- 1128 Attachment 3 Page 27

Attachment 3 RADTRAD Control File Inventory File SLB_4mc.nif

EC-RADN-1 128 Attachment 3 Page 2,8

Nuclide Inventory Name:SSESSLB 4mc.nifSSES SLBPower Level:40320.1000E+01

Nuclides:16

Nuclide 001:1-131

20.6956000000E+060.1310E+030.4790E+02

Xe-131m 0.1100E-01none 0.OOOOE+00none 0.OOOOE+00Nuclide 002:1-132

20.8390000000E+040.1320E+030.4420E+03

none 0.0000E+00none 0.0000E+00none 0.0000E+00Nuclide 003:1-133

20.7533000000E+050.1330E+030.3280E+03

Xe-133m 0.2900E-01Xe-133 0.9700E+00none 0.OOOOE+00Nuclide 004:1-134

20.3150000000E+040.1340E+030.8850E+03

none 0.OOOOE+00

none 0.OOOOE+00none 0.OOOOE+00Nuclide 005:1-135

20.2423100000E+050.1350E+030.4790E+03

Xe-135m 0.1500E+00Xe-135 0.8500E+00none 0.OOOOE+00Nuclide 006:Xe-131m

10.1036000000E+070.1310E+030.1810E-02

none 0.OOOOE+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 007:Xe-133m

10.1987032000E+060.1330E+030.3390E-01


Xe-133nonenoneNuclideXe-133

1

0. 1000E+010.0000E+000.0000E+00

008:

0. 4 5 5 3380000E+060.1330E+03'0.9890E+00

.none 0.0000E+00none 0.0000E+00none 0.0000E+00Nuclide 009:Xe-135m

10. 9 3 6 0 000000E+030. 1350E+030.3150E+01

Xe-135 0.1000E+01Cs-135 0.4500E-04none 0.0000E+00Nuclide 010:Xe-135

10. 3 2 8 6 800000E+050.1350E+030.2750E+01

Cs-135 0.1000E+01none 0.0000E+00none 0.0000E+00Nuclide 011:Kr-83m

10.684 0 000000E+040.8300E+020.4190E+00

none 0.0000E+00none 0.0000E+00none 0.0000E+00Nuclide 012:Kr-85m

10.1 5 6 9 600000E+050.8500E+020.7290E+00

Kr-85 0.2100E+00none 0.0000E+00none 0.0000E+00Nuclide 013:Kr-87

10. 4 6 8 0 000000E+040.8700E+020.2360E+01

Rb-87 0.1000E+01none 0.0000E+00none 0.0000E+00Nuclide 014:Kr-88

10. 9 9 7 2 400000E+040.8800E+02O.02450E+01

Rb-,88 0.1000E+01none 0.0000E+00none 0.-000E+0,

EC-RADN-1 128. Attachment 3 Page 30

Nuclide 015:Kr-85

10.3382974720E+090.8500E+020.2430E-02

none O.OOOOE+00none O.OOOOE+00none 0.OOOOE+00

Nuclide 016:Xe-138

10.8490000000E+030.1380E+030.1100E+02

Cs-138 0.1000E+01none 0.0000E+00none 0.OOOOE+00.

End of Nuclear Inventory File


Attachment 4 RADTRAD Control File Inventory File SLBpt2mc.nif


Nuclide Inventory Name:SSESSLBpt2mc.nifSSES SLBPower Level:40320.1000E+01

Nuclides:16

Nuclide 001:1-131

20.6956000000E+060.1310E+030.2400E+01

Xe-131m 0.1100E-01none 0.OOOOE+00none 0.OOOOE+00Nuclide 002:1-132

20.8390000000E+040.1320E+030.2210E+02

none 0.0000E+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 003:1-133

20.7533000000E+050.1330E+030.1640E+02

Xe-133m 0.2900E-01Xe-133 0.9700E+00none 0.OOOOE+00Nuclide 004:1-134

20.3150000000E+040.1340E+030.4420E+02

none 0.OOOOE+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 005:1-135

20.2423100000E+050.1350E+030.2400E+02

Xe-135m 0.1500E+00Xe-135 0.8500E+00none 0.OOOOE+00Nuclide 006:Xe-131m

10.1036000000E+070.1310E+030.1810E-02

none 0.OOOOE+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 007:Xe-133m

10. 1987,03200OE+060.133:OE+030.3390E-01

EC-RADN-1 128. Attachment 4 Page 33

Xe-133 0.1000E+01none 0.0000E+00-none 0.OOOOE+00Nuclide 008:Xe-133

10.4553380000E+060.1330E+030.9890E+00

none 0.0000E+00none 0.0000E+00none 0.OOOOE+00Nuclide 009:Xe-135m

10.9360000000E+030.1350E+030.3150E+01

Xe-135 0.1000E+01Cs-135 0.4500E-04none 0.OOOOE+00Nuclide 010:Xe-135*1

0.3286800000E+050.1350E+030.2750E+01

Cs-135 0.1000E+01none 0.OOOOE+00none 0.OOOOE+00Nuclide 011:Kr-83m

1

0.6840000000E+040.8300E+020.4190E+00

none 0..OOOOE+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 012:Kr-85m

10.1569600000E+050.8500E+020.7290E+00

Kr-85 0.2100E+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 013:Kr-87

10.4680000000E+040.8700E+020.2360E+01

Rb-87 0.1000E+01none 0.OOOOE+00none 0.OOOOE+00Nuclide 014:Kr-88

10.9972400000E+040.8800E+020.2450E+01

Rb-88 0.1000E+01none 0.OOOOE+00none 0.OOOOE+00


Nuclide 015:Kr-85

10.3382974720E+090.8500E+020.2430E-02

none 0.OOOOE+00none 0.OOOOE+00none 0.OOOOE+00

Nuclide 016:Xe-138

10.8490000000E+030.1380E+030.1100E+02

Cs-138 0.1000E+01none 0.OOOOE+00none 0.OOOOE+00

End of Nuclear Inventory File


Attachment 5 RADTRAD Output TBMST_500cfm_4mcDE_1 128.out

EC-RADN-1128 Attachment 5 Page 36

#######################################################################RADTRAD Version 3.03 (Spring 2001) run on 10/24/2006 at 12:59:23

#######################################################################

#######################################################################File information

########################################################4##############

Plant file = C:\Program Files\radtrad3.03\EC-RADN-1128_RiRADTRAD\TBMSTO50cfm_4mcDE_1l28.psfInventory file = c:\programfiles\radtrad3.03\ec-radn-1128_rlradtrad\slb,4mc.nifRelease file = c:\program files\radtrad3.03\ec-radn-1128_rl radtrad\slb.rftDose Conversion file = c:\program files\radtrad3.03\ec-radn-1128_rl radtrad\slb_phase 2.inp

*ata 3.03 4/15/420401

Radtad303E 415/00

Compartments:3

Compartment 1:SSES TB MS Tunnel

34 .4000E+0400000

Compartment 2:Environment

20 .OOOOE+000.0000

Compartment 3:SSES CR

15. 1800E+65.00

00,

Pathways:4


Pathway 1:SSES MST to Environs

1

22

Pathway 2:Environment

232

Pathway 3:Environment

2.3

2

to SSES CR - 6391 cfm Normal Intake

to SSES CR -500+10 cfm Unfiltered Inleakage

Pathway 4:'SSES CR to Environment

322

- CR Exhaust

End of Plant Model FileScenario Description Name:

Plant Model Filename:

Source Term:1

1 1.0000E+00c:\program files\radtrad3.03\ec-radn-1128 rl radtrad\slbphase 2.inpc:\program files\radtrad3.03\ec-radn-1128 rl radtrad\slb.rft

0.0000E+001

9.5000E-01 4.8500E-02 1.5000E-03 1.0000E+00Overlying Pool:

00.0000E+000000

Compartments:3

Compartment 1:110000000


Compartment 3:110


000000

Pathways:4

Pathway 1:000001

o .OOOOE+003 .3300E-027. 2000E+02

000000

Pathway 2:0000013o .OOOOE+006. 6600E-027 .2000E+020.0

000

Pathway 3:0000013o .OOOOE+006. 6600E-02*7.2000E+02000000

Pathway 4:000001

2.2000E+06o.OOOOE+00o.OOOOE+00

o.OOOOE+00o.OOOOE+00o.OOOOE+00

0.OOOOE+00o.OOOOE+00o.OOOOE+00


6.3910E+036.3910E+030.OOOOE+00


o.OOOOE+001.OOOOE+02o.OOOOE+00


5. 1000E+025. 1000E+020.OOOOE+00


0.OOOOE+001.OOOOE+020.OOOOE+00


EC-RADN-I 128 Attachment 5 Page 39

30.0000E+005. OOOOE-017.2000E+02000

6. 9010E+036. 9010E+030.OOOOE+00

o .OOOOE+OOo .000E+000.0000E+00

o .OOOOE+OOo .OOOOE+00o .OOOOE+0O

O .OOOOE+OOo .OOOOE+00o . 000E+00

000

Dose Locations:3

Location 1:EAB - MST Release

2130.0000E+002.0000E+007.2000E+0214o.0000E+008.0000E+002.4000E+01

7.2000E+02

0Location 2:MSLB @ LPZ -

215o.OOOOE+008.0000E+002.4000E+019.6000E+017.2000E+0214o.OOOOE+008.OOOOE+002.4000E+017.2000E+020

Location 3:MSLB @ CR -

30120.0000E+007.2000E+021

* 8.3000E-048.3000E-04o.OOOOE+00

3.5000E-041.8000E-042.3000E-04o.OOOOE+00

MST Release

4.9000E-053.50OOE-051.7000E-056. 1000E-060.0000E+00

3.50OOE-041.8000E-042.3000E-04o.OOOOE+00

MST Release

3.4700E-040.OOOOE+00

4O.OOOOE+00 1.OOOOE+002.4000E+01 6.OOOOE-019.6000E+01 4.OOOOE-017.2000E+02 0.OOOOE+00

Effective Volume Location:130.OOOOE+00 6.3000E-04-6.66OOE-02 0.OOOOE+007.200'OE+02 O.OOOE+00

Simulation Parameters:4

EC-RADN-t 128

O.OOOE+00 I.000OE-041.O000E-02 1.0000E-031.000E-01 1.OOOOE-027.2000E+02 O.OOOOE+00

Output Filename:C:\Program Files\radtrad3.o5

11101

End of Scenario File

Attachment 5 Page 40


#######################################•################################

RADTRAD Version 3.03 (Spring 2001) run on 10/24/2006 at 12:59:23#######################################################################

#####################################4##################################

Plant Description#######################################################################

Number of Nuclides = 16

Inventory Power 1.OOOOE+00 MWthPlant Power Level = 1.OOOOE+00 MWth

Number of compartments = 3

Compartment information

Compartment number 1 (Source term fraction = 1.OOOOE+00

Name: SSES TB MS TunnelCompartment volume = 4.4000E+04 (Cubic feet)Compartment type is NormalPathways into and out of compartment 1

Exit Pathway Number 1: SSES MST to Environs

Compartment number 2Name: EnvironmentCompartment type is EnvironmentPathways into and out of compartment 2

Inlet Pathway Number 1: SSES MST to EnvironsInlet Pathway Number 4: SSES CR to Environment - CR ExhaustExit Pathway Number 2: Environment to SSES CR - 6391 cfm Normal IntakeExit Pathway Number 3: Environment to SSES CR -500+10 cfm Unfiltered Inle

Compartment number 3Name: SSES CRCompartment volume = 5.1800E+05 (Cubic feet)Compartment type is Control RoomPathways into and out of compartment 3

Inlet Pathway Number 2: Environment to SSES CR - 6391 cfm Normal IntakeInlet Pathway Number . 3: Environment to SSES CR -500+10 cfm Unfiltered InleExit Pathway Number 4: SSES CR to Environment - CR Exhaust

Total number of pathways = 4


#########################################################4##############RADTRAD Version 3.03 (Spring 2001) run on 10/24/2006 at 12:59:23

#######################################################################

#######################################################################Scenario Description###################################################### #################

Radioactive Decay is enabledCalculation of Daughters is enabled

Release Fractions and TimingsGAP EARLY IN-VESSEL

0.000000 hr 0.0000 hrsNOBLES 1.OOOOE+00 0.OOOOE+00IODINE 1.0000E+00 0.OOOOE+00CESIUM 0.OOOOE+00 0.OOOOE+00TELLURIUM 0.OOOOE+00 0.OOOOE+00STRONTIUM 0.OOOOE+00 0.OOOOE+00BARIUM 0.OOOOE+00 0.OOOOE+00RUTHENIUM 0.OOOOE+00 0.OOOOE+00CERIUM 0.OOOOE+00 0.OOOOE+00LANTHANUM 0.OOOOE+00 0.OOOOE+00

LATE RELEASE0.0000 hrs0. 0000E+000. OOE+000 .OOOOE+000 .OOOOE+000 OOOOE+000 .OOOOE+000 OOOOE+000 OOOOE+000. O00OE+00

RELEASE MASS(gm)

1.322E-058. 936E-040.OOOE+000.OOOE+000.OOOE+000.OOOE+000. OOOE+000. OOOE+000. OOOE+00

Inventory Power = 1. MWt

NuclideName

1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83mKr-85mKr-87Kr-88Kr-85Xe-138

Nuclide1-131i-1331-135Xe-133mXe-135mXe-135Kr-85mKr-87Kr-88Xe-138

Group SpecificInventory

(Ci/MWt)2 4.790E+012 4.420E+022 3.280E+022 8.850E+022 4.790E+02.1 1.810E-031 3.390E-021 9.890E-011 3.150E+001 2.750E+001 4.190E-011 7.290E-011 2.360E+001 2.450E+001 2.430E.-031 1.100E+01

halflife(s)

6 956E+058.390E+037.533E+043.150E+032 .423E+04

1.036E+061. 987E+054. 553E+059. 360E+023 .287E+046. 840E+031. 570E+044.680E+039. 972E+033 .383E+088.490E+02

Whole BodyDCF

(Sv-m3/Bq-s)1.820E-141.120E-132.940E-141.300E-138. 294E-143.378E-161.370E-151. 560E-152. 040E-141. 190E-141. 500E-187 .480E-154. 120E-141. 020E-131. 190E-165. 770E-14

InhaledThyroid(Sv/Bq)

2. 920E-071. 740E-094. 860E-082. 880E-108. 460E-090. OOOE+000 OOOE+000 OOOE+000. OOOE+000 . OOOE+000 OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+000 OOOE+00

Daughternonenonenonenonenonenonenonenonenonenone

InhaledEffective

(Sv/Bq)8.890E-091.030E-101.580E-093.550E-113.320E-100.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000. OOOE+000. OOOE+000.OOOE+000.OOOE+000.OOOE+00

Fraction0 .000.000.000.000.000.000.000.000.000.00

DaughterXe-131mXe-133mXe-135mXe-133Xe-135Cs-135Kr-85Rb-87Rb-88Cs-138

Fraction0.01.0.03

0.151.001.001.00

0.211.001.001.00

DaughternoneXe-133Xe-135noneCs-135nonenonenonenonenone

Fractior0.000.970.850.000.000.000.000.000.000.00

Iodine fractionsAerosolElementalOrganic

COMPARTMENT DATA

9. 50OOE-014.8500E-021.50OOE-03

EC-RADN- 1128

-Compartment number 1: SSES TB MS Tunnel

Compartment number 2: Environment

Compartment number 3: SSES CR

PATHWAY DATA

Pathway number 1: SSES MST to Environs

Pathway Filter: Removal Data


Time (hr)

0.0000E+003.3300E-027.2000E+02

Flow Rate(cfm)

2.2000E+06o.0000E+00o.0000E+00

. Filter Efficiencies (%)Aerosol Elemental Organic

0.0000E+00 0.OOOOE+00 0.0000E+000.0000E+00 0.OOOOE+00 0.0000E+000.0000E+00 0.0000E+00 0.0000E+00

Pathway number 2: Environment to SSES CR - 6391 cfm Normal Intake


Time (hr)

0.0000E+006.6600E-027.2000E+02

Flow Rate(cfm)

6.3910E+03*6.3910E+03

o.0000E+00

Filter Efficiencies (%)Aerosol Elemental Organic

0.0000E+00 0.0000E+00 0.OOOOE+000.0000E+00 1.0000E+02 1.OOOOE+020.0000E+00 0.0000E+00 0.0000E+00

Pathway number 3: Environment to SSES CR -500+10 cfm Unfiltered Inle


Time (hr)

0.0000E+006.6600E-027.2000E+02

Flow Rate(cfm)

5. 1000E+025. 1000E+020.0000E+00


0.0000E+00 0.OOOOE+00 0.OOOOE+000.0000E+00 1.0000E+02 1.0000E+020.0000E+00 0.0000E+00 0.OOOOE+00

Pathway number 4: SSES CR to Environment - CR Exhaust


Time (hr)

0.0000E+005. 0000E-017.2000E+02

Flow Rate(cfm)

6.9010E+036. 9010E+030.0000E+00


O.0000E+00 0.OOOOE+00 0.OOOOE+000.0000E+00 0.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+00 0.0000E+00

LOCATION DATALocation EAB - MST Release is in compartment 2

Location X/Q DataTime (hr)

0.OOOOE+002.OOOOE+007.2000E+02

X/Q (s * m -3)8.3000E-048.3000E-040.OOOOE+00

Location Breathing Rate DataTime (hr) Breathing

0.OOOOE+008.OOOOE+002.4000E+017.2000E+02

Location MSLB 4 LPZ - MST Rel

Rate (m'3 * sec^-l)3.5000E-041.8000E-042.3000E-040.0o0oE+00ease is in comp artment 2

Location X/Q Data

EC-RADN-1 128

Time -(hr)0.0000E+008.0000E+002.4000E+019.6000E+017.2000E+02

Location BreathTime (hr)

0.0000E+008.0000E+002.4000E+017.2000E+02

Location MSLB @

Location X/Q DaTime (hr)

o.0000E+006.6600E-027.2000E+02

Location BreathTime (hr).0.0000E+007.2000E+02

Location OccupaTime (hr)

0.0000E+002.4000E+019.6000E+017.2000E+02

USER SPECIFIED TIMETime

0.0000E+001.OOOOE-021.OOOOE-017.2000E+02

Attachment 5

X/Q (s * m^-3)4.9000E-053.5000E-051.7000E-056.1000E-060.OOOOE+00

Ling Rate DataBreathing Rate (m'3 * sec'-1)

3.5000E-04.1.8000E-042.3000E-040.0000E+00

CR - MST Release is in compartmen

.taX/Q (s * m'-3)

6.3000E-040.0000E+000.0000E+00

Ling Rate DataBreathing Rate (mW3 * sec^-1)

3.4700E-040.0000E+00

*ncy Factor DataOccupancy Factor

1.OOOOE+006.OOOOE-014.OOOOE-010.000OE+00

STEP DATA - SUPPLEMENTAL TIME STEPSTime step

1.OOOOE-041.OOOOE-031.OOOOE-020.OOOOE+00

Page 44

t 3


#######################################################################RADTRAD Version 3.03 (Spring 2001) run on 10/24/2006 at 12:59:23

#######################################################################

44 ##4#444#4444#4#4444# 44# 44## 444# 44#4#44####44444tft

444 * * #44 444 # 4 4#4

#1#1

44 ft ft ft 4 ft 4

#44 #444

ft# 4 ft 4 4

ft 44. 4

4 4 44444 4

####################################################################Dose, Detailed model and Detailed Inventory Output

####################################################################

Detailed model information at time (H) = 0.0000

EAB - MST Release Doses:

Time (h) = 0.0000Delta dose (rem)

Accumulated dose (rem)

Whole Body1.5193E-041.5193E-04

MSLB @ LPZ - MST Release Doses:

Time (h) = 0.0000Delta dose (rem)Accumulated dose (rem)

Whole Body8.9694E-068.9694E-06

Thyroid8. 6221E-038.6221E-03

Thyroid5.0901E-045. 0901E-04

Thyroid3.9624E-103.9624E-10

TEDE4.4260E-044.4260E-04

TEDE2.6129E-052.6129E-05

TEDE1.3871E-111.3871E-11

MSLB @ CR - MST Release Doses:


Whole Body5.1270E-135.1270E-13

SSES TB MS

Time (h) =


Tunnel Compartment Nuclide Inventory:

0.0000 Ci4. 7889E+014.4190E+023.2792E+028.8480E+024.7889E+021.8096E-033.3892E-029. 8877E-013.1493E+002.7494E+004.1890E-017.2883E-012.3595E+002.4494E+00.2.4294E-031.0997E+01

kg3.8681E-074.3379E-082. 9122E-073.3104E-081.3886E-072. 1769E-117. 9393E-115. 3077E-093.5274E-111.0814E-092. 1080E-118. 6191E-118. 5154E-111. 9053E-106. 1923E-09.1. 1421E-10

Inventory:Sump

0.0000E+000.OOOOE+000.0000E+00

Atoms1.7782E+181.9791E+171.3186E+181.4878E+176. 1942E+171. 0007E+143.5949E+142.4033E+161.5735E+144.8237E+151. 5295E+146.1065E+145.8943E+141.3039E+154.3871E+164.9840E+14

Decay9.7468E+088.9939E+096.6742E+091.8008E+109.7468E+093.6830E+046.8981E+052.0124E+076.4097E+075.5958E+078.5259E+061.4834E+074.8022E+074.9853E+074.9447E+042.2383E+08

'SSES TB MS Tunnel Transport GroupTime (h) = 0.0000 AtmosphereNoble gases (atoms) 7.6500E+16Elemental I (atoms) 1.9705E+17Organic I (atoms) 6.0943E+15

EC-RADN-1 128

Aerosols (kg)Dose EffectiveDose EffectiveTotal I (Ci)


8.4870E-07 0.0000E+00(Ci/cc) 1-131 (Thyroid)(Ci/cc) 1-131 (ICRP2.Thyroid)

9.6191E-081.6567E-072.1814E+03

SSES MST to Environs Transport Group Inventory:

Time (h) = 0.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)

PathwayFiltered

0.0000E+000.0000E+000.OOOOE+000.OOOOE+00

Transported1.7535E+134.5167E+131.3969E+121.9454E-10

SSES CR Compartment Nuclide Inventory:

Time (h) =


0.0000 Ci2 .2523E-05

2.0783E-041.5423E-044.1614E-042.2523E-048.5109E-101.5940E-084.6504E-071.4812E-061.2931E-061.9702E-073.4279E-071.1097E-061.1520E-061.1426E-095.1723E-06

kg1.8192E-132 .0402E-141 .3697E-131 .5570E-146. 5307E-141. 0238E-173. 7340E-172 .4963E-151.6590E-175. 0858E-169. 9144E-184. 0537E-174. 0050E-178. 9612E-172. 9124E-155. 3715E-17

Atoms8. 3631E+119. 3080E+106. 2017E+116. 9972E+102. 9132E+114 .7066E+07

1. 6907E+081. 1303E+107. 4005E+072 .2687E+09

7. 1935E+072. 8720E+082 .7722E+08

6. 1325E+082. 0634E+102. 3441E+08

Decay4.5841E+024.2300E+033.1390E+038.4696E+034.5841E+031.7322E-023. 2443E-019.4650E+003.0146E+012.6318E+014.0099E+006.9767E+002.2586E+012 .3447E+01

2.3256E-021.0527E+02

SSES CR Transport Group Inventory:Time (h) = 0.0000 Atmosphere SumpNoble gases (atoms) 3.5980E+10 0.0000E+00Elemental I (atoms) 9.2677E+10 0.OOOOE+00Organic I (atoms) 2.8663E+09 0.OOOOE+00Aerosols (kg) 3.9916E-13 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

3.8428E-156.6186E-151.0260E-03

Environment to SSES CR - 6391 cfm Normal Intake Transport Group Inventory:


PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00


Environment to SSES CR -500+10 cfm Unfiltered Inle Transport Group Inventory:

Time (h) = 0.0000Noble gases (atoms)

Elemental I (atoms)Organic I (atoms)Aerosols (kg)

PathwayFiltered



SSES CR to Environment - CR Exhaust Transport Group Inventory:

PathwayFiltered TransportedTime (h) = 0.0000

EC-RADN-1 128

Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)


1.4648E+033.7732E+031. 1670E+021.6251E-20

0.OOOOE+000.OOOOE+000.0000E+000.OOOOE+00

Detailed model information at time (H) =


0.0333


Whole Body6.6273E-016.6288E-01



Whole Body3.9125E-023 9134E-02

Thyroid3. 7615E+013.7624E+01

Thyroid2.2206E+002.2211E+00

Thyroid7.3581E-017.3581E-01

TEDE1.9308E+001.9312E+00

TEDE1.1399E-011.1401E-01

TEDE2.5742E-022.5742E-02


Time (h) = 0.0333 Whole BodyDelta dose (rem) 9.4493E-04Accumulated dose (rem) 9.4493E-04

SSES TB MS Tunnel Compartment Nuclide Inventory:

Time (h) = 0.0333 Ci kg Atoms Decay

SSES TB MS Tunnel Transport Group Inventory:Time (h) = , 0.0333 Atmosphere SumpNoble gases (atoms) 3.2899E-27 0.OOOOE+00Elemental I (atoms) 8.0858E-27 0.OOOOE+00

Organic I (atoms) 2.5008E-28 0.OOOOE+00Aerosols (kg) 3.4825E-50 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

3.9512E-516. 7883E-518.8515E-41



PathwayFiltered


Transported.7.6518E+161.9701E+176.0932E+158.4855E-07

'SSES CR Compartment Nuclide Inventory:

Time (h)1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83mKr-85mKr-87Kr-88Kr-8'5

= 0.0333 Ci9.5716E-028.7463E-016.5478E-011.7226E+009. 5400E-013.7014E-067.5664E-052. 0921E-031.7949E-027.5635E-038.2726E-041.4492E-034.6334E-034.8557E-034.8564E-06

kg7. 7311E-108.5859E-115.8149E-106.4451E-112.7662E-104.4527E-141.7724E-131. 1230E-112.0104E-132. 9748E-124.1629E-141. 7138E-131.6722E-133. 7771E-131.2378E-11

Atoms3.5540E+153.9171E+142.6329E+152.8965E+141.2339E+152.0469E+118.0255E+115.0851E+138. 9680E+II1.3270E+133.0205E+ll1.2142E+121. 1575E+122.5848E+128. 7698E+13

Decay4 .2641E+113. 9155E+122. 9185E+127. 7755E+124. 2571E+121. 6298E+073 .1912E+08

9. 0578E+095 3889E+102. 9000E+103 .7076E+09

6. 4729E+092. 0824E+102. 1721E+102. 1634E+07


Xe-138 1.9934E-02 2.0701E-13 9.0338E+11 9.3271E+10

SSES CR Transport Group Inventory:Time (h) = 0.0333 Atmosphere SumpNoble gases (atoms) 1.5988E+14 0.OOOOE+00Elemental I (atoms) 3.9296E+14 0.OOOOE+00Organic I (atoms) 1.2153E+13 0.OOOOE+00Aerosols (kg) 1.6925E-09 O.0000E+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

1.6311E-112. 8023E-114.3017E+00



PathwayFiltered

0.OOOOE+00O.OOOOE+000.0000E+000.OOOOE+00




PathwayFiltered





PathwayFiltered

4. 1748E+121.0505E+133.2491E+114 .5247E-II

Transported0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00



0.0666


Whole Body0.OOOOE+006.6288E-01


Time (h) = 0.0666Delta dose (rem).Accumulated dose (rem)


Thyroid0.OOOOE+003.7624E+01


Thyroid7.2291E-011.4587E+00

TEDE0.OOOOE+001.9312E+00

TEDE0.OOOOE+001.1401E-01

TEDE2.5259E-025.1001E-02



Whole Body9.1445E-041.8594E-03

,SSES TB MS Tunnel Compartment Nuclide Inventory:


'SSES TB MS Tunnel Transport GroupTime (h) = 0.066-6 AtmosphereNoble gases <atoms) 3.4328E-27

Inventory:'Sump

0.000OE+O0


Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

8.0669E-27 0.0000E+002.4949E-28 0.0000E+003.4743E-50 0.0000E+001-131 (Thyroid)1-131 (I-CRP2 Thyroid)

3.9458E-516.7626E-518.7333E-41


Time (h) = 0.0666Noble gases (atoms)Elemental I (atoms)*Organic I (atoms)Aerosols (kg)

PathwayFiltered

0.0000E+000.OOOOE+000.OOOOE+000.0000E+00



Time (h)1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83mKr-85mKr-87Kr-88Kr-85Xe-138

0.0666 Ci9. 3191E-028.4.326E-016.3688E-011.6337E+009. 2576E-013.6861E-068.1372E-052. 1496E-032.7825E-029.3935E-037.9580E-041.4037E-034.4323E-034.6889E-034.7289E-061.7600E-02

kg7. 5271E-108.2780E-115.6559E-106. 1124E-I12.6843E-104.4343E-141.9062E-131.1539E-113.1165E-133.6945E-124. 0046E-141.6600E-131.5996E-133.6474E-131.2053E-111.8278E-13

Atoms3 .4603E+15

3 . 7766E+14

2.5610E+152.7470E+141. 1974E+152.0385E+II8.6309E+115.2248E+131.3902E+121.6481E+132 .9056E+11

1.1761E+121.1073E+122 .4960E+128.5396E+137. 9764E+11

Decay8.4518E+117. 7235E+125. 7818E+12

1. 5214E+138. 4240E+123 .2671E+076. 6688E+081. 8456E+101. 5510E+116. 6488E+107. 3053E+091. 2797E+104. 0919E+104 .2878E+104. 2882E+071. 7637E+11

SSES CR Transport Group Inventory:Time (h) = 0.0666Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

Atmosphere Sump1.6245E+14 0.OOOOE+003.8174E+14 0.OOOOE+001.1806E+13 0.OOOOE+001.6441E-09 0.OOOOE+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

1. 5861E-112 .7183E-114.1328E+00



PathwayFiltered





PathwayFiltered






PathwayFiltered

8.4627E+122 .0816E+13

6.4378E+118.9651E-11




0.5000

Time (h) = •0.5000Delta dose (rem)Accumulated dose (rem)



Time (h) = 0.5000 Whole BodyDelta dose (rem) 0.OOOOE+00Accumulated dose (rem) 3.9134E-02



Thyroid0.OOOOE+002..2211E+00

Thyroid7.7797E+009.2384E+00



* TEDE

2.6984E-013 .2084E-01


Whole Body8.9523E-031.0812E-02



SSES TB MS Tunnel Transport Group Inventory:Time (h) = 0.5000 Atmosphere * SumpNoble gases (atoms) 5.2536E-27 0.OOOOE+00Elemental I (atoms) 7.8418E-27 0.OOOOE+00Organic I (atoms) 2.4253E-28 0.OOOOE+00Aerosols (kg) 3.3765E-50 0.0000E+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

3.8797E-516.4621E-517.4097E-41



PathwayFiltered




Time (h)1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83mKr-85mKr-87

0.5000 Ci6.5803E-025.2423E-014 .4398E-018.1962E-016.2612E-013.3599E-061.2763E-042.5459E-037.2562E-022.5681E-024.8049E-049.2660E-042.4878E-03

kg5 .3150E-I05. 1462E-113. 9429E-103. 0666E-111. 8155E-104. 0419E-142. 9897E-131.3666E-118.1273E-131.0101E-112.4179E-141.0958E-138. 9786E-14

Atoms2 .4433E+152 3478E+141. 7853E+151. 3782E+148. 0986E+141 .8581E+11

1. 3537E+126. 1879E+133. 6255E+124 . 5058E+131. 7543E+117. 7635E+116 .2150E+11

Decay5.3720E+124.6327E+133 .6533E+138.3101E+135.2494E+132.3570E+086.8483E+091.5551E+113. 5081E+121. 1237E+124.3251E+107. 8866E+102.3459E+11


Kr-88Kr-85Xe-138

2.9752E-033.3449E-063.4822E-03

2.3143E-13 1.5838E+128.5257E-12 6.-0404E+133.6163E-14 1.5781E+11

2 . 5957E+112.7278E+086.7765E+ll


Atmosphere Sump1.7582E+14 0.0000E+002.6244E+14 0.OOOOE+008.1166E+12 0.OOOOE+001.1300E-09 0.0000E+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

1.1029E-111.8370E-112.4798E+00



PathwayFiltered





PathwayFiltered





PathwayFiltered

6.7737E+131.3111E+144.0549E+125.6461E-10




2.0000






Thyroid0.OOOOE+003 .7624E+01


Thyroid1.2732E+012. 1970E+01

TEDE0.OOOOE+001. 9312E+00


TEDE4 .3247E-017. 5331E-01



Whole Body1.0685E-022.1497E-02



SSES TB MS Tunnel Transport Group Inventory:


Time (h) = 2.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

Atmosphere Sump1.0907E-26 0.OOOOE+007.2681E-27 0.OOOOE+002.2479E-28 0.OOOOE+003.1273E-50 0.0000E+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

3.6826E-515. 7404E-514. 8101E-41



PathwayFiltered





2.0000 Ci1.9732E-021 .0117E-011 .2737E-017 .5307E-021 .6175E-011 .7942E-061 .0843E-041 .7988E-032 .5429E-022 .5626E-028. 3811E-052 .2009E-043 .3709E-046. 1629E-041. 0090E-061 .2778E-05

kg1.5938E-I09. 9314E-121. 1311E-102. 8176E-124. 6901E-112 .1584E-142 .5399E-139. 6562E-122 .8482E-131. 0079E-114 .2176E-152 .6028E-141 .2166E-144 7940E-142. 5719E-121. 3270E-16

Atoms7.3268E+144 .5309E+135. 1216E+141.2663E+132. 0922E+149. 9224E+101. 1501E+124.3722E+131.2705E+124.4961E+133.0601E+101. 8440E+118.4212E+103 .2807E+111. 8221E+135.7907E+08

Decay1.2984E+139. 7503E+138.6991E+131.4515E+141.2077E+147.4533E+083 .2529E+106. 1076E+111.3160E+136. 9798E+128.8456E+101. 7667E+114.4871E+115. 5774E+116.6066E+088. 0076E+11

SSES CR Transport Group Inventory:Time (h) = 2.0000 Atmosphere SumpNoble gases (atoms) 1.1005E+14 0.OOOOE+00Elemental I (atoms) 7.3334E+13 0.OOOOE+00Organic I (atoms) 2.2680E+12 0.OOOOE+00Aerosols (kg) 3.1554E-10 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

3 .1562E-124.9198E-124.8533E-01



PathwayFiltered




Time (h) = 2.0000Noble gases (atoms)Elemental I (atoms)-organic I (atoms)Aerosols (kg)

PathwayFiltered






PathwayFiltered

2.4520E+143.0859E+149.5441E+121.3286E-09

Transported0.OOOOE+000.0000E+000.0000E+000.0000E+00



8.0000





Thyroid0.OOOOE+003. 7624E+01


Thyroid5.1015E+002. 7072E+01


TEDE0.OOOOE+001. 1401E-01

TEDE1.6864E-019.2195E-01



Whole Body2.4730E-032.3970E-02



SSES TB MS Tunnel Transport Group Inventory:Time (h) = 8.0000 Atmosphere SumpNoble gases (atoms) 2.5589E-26 0.OOOOE+00Elemental I (atoms) 6.0442E-27 0.OOOOE+00Organic I (atoms) 1.8693E-28 0.OOOOE+00Aerosols (kg) 2.5957E-50 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

3.1276E-514. 3828E-512.2652E-41


Time (h) = 8.0000Noble gases,(atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)

PathwayFiltered




Time (h) =

1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83m

8.0000 Ci1.5956E-041.4033E-048.6267E-045.3669E-067.2045E-044.0067E-082.8372E-064.4372E-051.1391E-044.9287E-047.7585E-08

kg1.2888E-121.3776E-147.6610E-132. 0080E-162 .0890E-134. 8200E-166.6462E-152.3819E-131.2759E-151.9385E-133.9042E-18

Atoms5. 9247E+126.2847E+103 . 4689E+129.0243E+089.3186E+ll2 .2158E+093.0094E+101. 0785E+125.6915E+098.6474E+112.8328E+07

Decay1. 6218E+131.0972E+141.0715E+141. 5142E+141.4445E+141.1420E+095.8790E+101.0328E+121.6851E+131.2847E+139.7999E+IOl


Kr-85mKr-87Kr-88Kr-85

7.0055E-071.1363E-071.1346E-068.3474E-09

8.2846E-17 5.8695E+084.1008E-18 2.8386E+078.8260E-17 6.0400E+082.1276E-14 1.5074E+11

2 . 0705E+114 .8226E+116.3550E+118.2680E+08


Atmosphere Sump2.1332E+12 0.0000E+005.0387E+11 0.0000E+001.5584E+10 0.0000E+002.1639E-12 0.0000E+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

2.2147E-143.1035E-141.8884E-03



PathwayFiltered

0.0000E+000.0000E+000.0000E+000.0000E+00



Time (h) = 8.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms),Aerosols (kg)

PathwayFiltered

0.0000E+000.0000E+000.0000E+000.0000E+00



Time (h) = 8.0000Noble gases (atoms)Elemental I *(atoms)Organic I (atoms)Aerosols (kg)

PathwayFiltered

3.9054E+143.7824E+141.1698E+131.6281E-09

Transported0.0000E+000.0000E+000.0000E+000.0000E+00




Whole Body0.0000E+006.6288E-01



Whole Body0.0000E+003.9134E-02

Thyroid0.0000E+003 .7624E+01

Thyroid0.0000E+002.2211E+00

Thyroid3.6358E-022.7108E+01

TEDE0.0000E+001.9312E+00

TEDE0.0000E+001.1401E-01

TEDE1.1688E-039.2312E-01



Whole Body8.2942E-062.3978E-02


Time *(h) = 24.0000 Ci kg Atoms Decay


SSES TB MS Tunnel Transport 'Group Inventory:Time (h) = 24.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

Atmosphere Sump3.7977E-26 0.OOOOE+004.5471E-27 0.0000E+001.4063E728 0.0000E+001.9466E-50 0.OOOOE+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

2.3029E-512. 8688E-519.5762E-42

SSES MST to Environs! Transport Group Inventory:


PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.0000E+00

Transported7.6518E+161.9701E+176. 0932E+158.4855E-07

SSES CR Compartment Nuclide Inventory.:

Time (h) = 24.00001-1311-1331-135Xe-131mXe-133mXe-133Xe-135Kr-85

Ci4 .2033E-101.4166E-093. 8691E-10.2. 8744E-131.6250E-112.6602E-101.0001E-092.3303E-14

kg3.3951E-181.2581E-181.1219E-193 .4578E-213.8066E-201.4280E-183. 9334E-195.9397E-20

Atoms1.5607E+075.6964E+065.0044E+051.5896E+041.7236E+056.4658E+061.7546E+064.2082E+05

Decay1. 6245E+131. 0729E+141. 4455E+141. 1495E+095. 9315E+101. 0410E+121 .2931E+138. 2819E+08

SSES CR Transport Group Inventory:Time (h) = 24.0000

Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

Atmosphere Sump8.8327E+06 0.OOOOE+001.0576E+06 0.OOOOE+003.2709E+04 0.OOOOE+004.5274E-18 0.0000E+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

4.5496E-205.6675E-202.2272E-09

Environment to SSES CR - .6391 cfm Normal Intake Transport Group Inventory:


PathwayFiltered


Transported1.4546E+143. 7452E+141.1583E+131.6130E-09



PathwayFiltered



SSES CR to Environment -. CR Exhaust Transport Group Inventory:

Time (h) = 24.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms)

PathwayFiltered

3.9282E+143 . 7873E+141.1713E+13

Transported0.OOOOE+000.OOOOE+000.0000E+O0

EC-RADN-1 128

Aerosols (kg)


1.6303E-09 0.OOOOE+00




Whole Bodyo.OOOOE+006.6288E-01



MSLB @ CR - MST Release Doses:.



Thyroid4.5228E-082.7108E+01


TEDE0. 000E+001.1401E-01

TEDE1.4197E-099.2312E-01


Whole Body4.4223E-122.3978E-02



SSES TB MSTime (h) =

Tunnel Transport Group Inventory:96.0000

Noble gases (atoms)Elemental I (atoms)Organic I (atoms).Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

Atmosphere Sump3.8638E-26 0.OOOOE+002.6232E-27 0.OOOOE+008.1131E-29 0.OOOOE+001.1184E-50 0.OOOOE+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

1.1953E-511.2407E-511.9578E-42



PathwayFiltered






Atmosphere Sump9.0939E-19 0.OOOOE+006.1741E-20 0.OOOOE+001.9095E-21 0.OOOOE+002.6324E-43 0.OOOOE+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

2.3896E-452.4805E-454.6079E-35


Time (h) = 96.0000Noble gases (atoms)Elemental I (atoms)-Organic I (atoms)

PathwayFiltered


Transported1.4546E+143.7452E+141.1583E+13

EC-RADN-1128

Aerosols (kg)


0.OOOOE+00 1.6130E-09



PathwayFiltered





PathwayFiltered

3.9282E+143.7873E+141.1713E+131.6303E-09



EAB 7 MST Release Doses:


Whole Body0.OOOOE+00

•6.6288E-01






Thyroid1.6032E-332. 7108E+01


TEDE0.0000E+001.1401E-01

TEDE4.9044E-359. 2312E-01



Whole Body3.4235E-382.3978E-02



SSES TB MS Tunnel Transport Group Inventory:Time (h) = 720.0000 Atmosphere SumpNoble gases (atoms) 3.3513E-27 0.OOOOE+00Elemental I (atoms) 2.6802E-28 0.OOOOE+00Organic I (atoms) 8.2893E-30 0.OOOOE+00Aerosols (kg) 1.1420E-51 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

1.1945E-521.1945E-521.4883E-43



PathwayFiltered



SSES-CR Compartment Nuclide Inventory.:



SSES CR Transport Group Inventory:Time (h) = 720.0000 Atmosphere SumpNoble gases (atoms) 1.8837-236 0.OOOOE+00Elemental I (atoms) 1.5065-237 0.OOOOE+00

Organic I (atoms) 4.6593-239 0.OOOOE+00Aerosols (kg) 6.4191-261 0.0000E+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

5.7032-2635.7032-2638.3656-253



PathwayFiltered

0.OOOOE+000.OOOOE+000.0000E+00

0.OOOOE+00




PathwayFiltered





.PathwayFiltered

3.9282E+143.7873E+141.1713E+131.6303E-09


72185

####################################################################1-131 Summary

####################################################################

Time (hr)0.0000.0330.0670.3300.5000.7501.0001.2501.5001.7502.0002.2502.5002.7503.0003.2503.5003.7504.0004.250

SSES TB MS Tunnel1-131 (Curies)

4.7889E+01

1.9695E-421.9693E-421.9674E-421.9662E-421.9645E-421.9627E-421.9609E-421.9592E-421.9574E-421.9557E-421.9539E-421.9522E-421.9504E-421.9487E-421.9469E-421.9452E-421.9434E-421.9417E-421.9400E-42

Environment1-131 (Curies)

1.0977E-024.7900E+014. 7900E+014. 7900E+014. 7900E+014. 7900E+014. 7900E+014. 7900E+014 .7900E+01

4. 7900E+014. 7900E+014 .7900E+01

4. 7900E+014.7900E+014 .7900E+01

4. 7900E+014 .7900E+01

4. 7900E+014 .7900E+014. 7900E+01

SSES CR1-131 (Curies)

2 .2523E-059. 5716E-029 .3191E-027. 5426E-026. 5803E-025. 3835E-024.4044E-023.6034E-022.9480E-022.4119E-021.9732E-021.6144E-021.3208E-021.0806E-028.8404E-037.2326E-035.9172E-034.8411E-033.9606E-033.2403E-03


4.5004.7505.0005.2505.5005.7506.0006.2506.5006.7507.0007.2507.5007.7508.0008.2508.5008.7509.0009.2509.5009.750

10.00010.25024.00096.000

720.000

1.9382E-421.9365E-421.9347E-421.9330E-421. 9313E-421.9295E-421. 9278E-421. 9261E-421.9244E-421.9226E-421. 9209E-42

1.9192E-421. 9175E-421. 9157E-421. 9140E-421. 9123E-421. 9106E-421.9089E-421.9072E-421.9055E-421.9038E-421.9020E-421.9003E-421.8986E-421. 8073E-421.3959E-421.4883E-43

4.7900E+014.7900E+014.7900E+014.7900E+014. 7900E+014.7900E+014.7900E+014.7900E+014 7900E+014.7900E+014 .7900E+014 .7900E+014 .7900E+014 .7900E+014.7900E+014 .7900E+014.7900E+014 .7900E+014 .7900E+014 .7900E+014.7900E+014.79.00E+014 .7900E+014.7900E+014.7900E+014.7900E+014 .7900E+01

2.6510E-032.1629E-031.7744E-031.4517E-031.1877E-039. 7168E-047.9496E-046. 5038E-045.3210E-044.3533E-043.5615E-042.9138E-042.3839E-041.9503E-041.5956E-041.3054E-041.0680E-048.7377E-057.1486E-055.8485E-054.7848E-05.3.9146E-053.2027E-052.6202E-054.2033E-103.2854E-358.3656-253

####################################################################Cumulative Dose Summary

####################################################################

EAB - MST Release

Time(hr)0.0000.0330.0670.3300.5000.7501.0001.2501.5001.7502.0002.2502.5002.7503.0003.2503.5003.7504.0004.2504.5004.7505.0005.2505.5005.7506.0006.2506.500-6.7507.000

Thyroid(rem)

0.0000E+003.7624E+013.7624E+013.7624E+013.7624E+013 .7624E+013.7624E+013.7624E+013 .7624E+013.7624E+013.7624E+013.7624E+013.7624E+013 .7624E+013.7624E+013.7624E+013 .7624E+013 .7624E+013 .7624E+013 .7624E+013 .7624E+013 .7624E+013.7624E+013.7624E+013.7624E+013 .7624E+013.7624E+013 .7624E+013.7624E+013.7624E+013.7624E+01

TEDE(rem)

0.0000E+001. 9312E+001.9312E+001.9312E+001.9312E+001.9312E+001. 9312E+001. 9312E+001. 9312E+001. 9312E+001.9312E+001.9312E+001. 9312E+001.9312E+001. 9312E+001. 9312E+001. 9312E+001.9312E+001. 9312E+001.9312E+001. 9312E+001.9312E+001. 9312E+001.9312E+001.9312E+001.9312E+001.9312E+001. 9312E+001. 9312E+001.9312E+001.9312E+00

MSLB @ LPZThyroid

(rem)0.0000E+002 .2211E+002.2211E+002.2211E+002.2211E+002.2211E+002. 2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+00

- MST Rele

TEDE(rem)

0. OOOE+001.1401E-011. 1401E-011. 1401E-011.1401E-011.1401E-011.1401E-011.1401E-011. 1401E-011.1401E-011.1401E-011.1401E-011.1401E-011.1401E-011.1401E-011.1401E-011.1401E-011. 1401E-011. 1401E-011. 1401E-011. 1401E-011.1401E-011.1401E-011.1401E-011. 1401E-011.1401E-011.1401E-011.1401E-011. 1401E-011.1401E-011.1401E-01

MSLB @ CR -

Thyroid(rem)

0.0000E+007.3581E-011.4587E+006 5184E+009.2384E+001.2597E+011.5322E+01i.7533E+011. 9329E+012 .0787E+012. 1970E+012 .2932E+012.3713E+012.4348E+012 .4864E+012 .5283E+012 .5624E+012 . 5901E+012 .6127E+012 .6310E+012.6459E+012 .6580E+012.6678E+012 .6758E+012.6824E+012.6877E+012.6920E+012.6955E+012.6983E+012.7007E+012.7026E+01

- MST ReleaTEDE(rem)

0.0000E+002.5742E-025. 1001E-022.2693E-013 .2084E-014.3612E-015.2906E-016.0407E-016 .6468E-017. 1367E-017.5331E-017. 8540E-018. 1139E-018.3245E-018.4953E-018.6337E-018. 7460E-018.8371E-018.9111E-018. 9711E-019. 0199E-019.0594E-019. 0916E-019. 1177E-019. 1389E-019.1562E-019.1702E-019.1816E-019.1909E-019.1984E-019.2045E-01


7 .2507 .5007.7508.0008.2508.5008.7509.0009.2509.500.9.75010.00010.25024 .00096.000

720.000

3.7624E+013 7624E+013 7624E+013 7624E+013 7624E+013 7624E+013 7624E+013 .7624E+01

3 . 7624E+013. 7624E+013. 7624E+013 .7624E+01

3 .7624E+01

3 .7624E+01

3 .7624E+01

3 . 7624E+01

1.9312E+001.9312E+001.9312E+001.9312E+001.9312E+001. 9312E+001 9312E+001.9312E+001. 9312E+001. 9312E+001.9312E+001.9312E+001. 9312E+001. 9312E+001. 9312E+001. 9312E+00

2. 2211E+002.2211E+0.02.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002.2211E+002. 2211E+002. 2211E+002. 2211E+002. 2211E+002.2211E+002.2211E+002.2211E+00

1.1401E-011.1401E-011.1401E-011. 1401E-011. 1401E-011. 1401E-011.1401E-011. 1401E-011. 1401E-011. 1401E-011.1401E-011.1401E-011.1401E-011.1401E-011. 1401E-011. 1401E-01

2.7041E+012 .7053E+012 .7064E+012.7072E+012.7079E+012. 7084E+012. 7089E+012 .7092E+012. 7095E+012. 7098E+012.7100E+012. 7101E+012. 7103E+012. 7108E+012. 7108E+012. 7108E+01

9.2095E-019.2135E-019.2168E-019.2195E-019.2217E-019.2235E-019.2249E-019.2261E-019.2270E-019.2278E-019.2284E-019.2289E-019.2294E-019.2312E-019.2312E-019. 2312E-01

####################################################################Worst Two-Hour Doses

####################################################################

EAB - MST

Time(hr)

0.0

ReleaseWhole Body

(rem)6.6288E-01

Thyroid(rem)

3 .7624E+01

TEDE(rem)

1.9312E+00


Attachment 6 RADTRAD Output TBMST_500cfm.2ptmcDE_1 128.out


############it##########################################################RADTRAD Version 3.03 (Spring 2001) run on 10/24/2006 at 13:01:07

##i#####it ####################i#####i################itit#####

########################################4###############################

File information#########################################################################

Plant file = C:\Program Files\radtrad3.03\EC-RADN-1128 R1 RADTRAD\TBMST_500cfmpt2mcDEll28.psf

Inventory file = C:\Program Files\radtrad3.03\EC-RADN-l128_RiRADTRAD\SLBspt2mc.nifRelease file = C:\Program Files\radtrad3.03\EC-RADN-1128_RiRADTRAD\SLB;RFTDose Conversion file = C:\Program Files\radtrad3.03\EC-RADN-1128_RiRADTRAD\SLBPhase 2.inp

Radtrad 3.03 4/15/2001*SSES MSLBNuclide Inventory File:C:\Program Files\radtrad3 .03\EC-RADN-1128_RiRAflTRAD\SLB-pt2mc.nifPlant Power Level:1. 0000E+00*

Compartments:3

Compartment 1:.SSES MS Tunnel

4.AOOO0E+0400000

Compartment 2:Environment

20. OOOOE+0000000

Compartment 3:SSES CR

1S. 1800E+050

000

Pathways:4

Pathway 1:


SSES MST to Environs122

Pathway 2:Environment to SSES CR

232

Pathway 3:Environment to SSES CR

232

Pathway 4:SSES CR to Environment

3

- 6391 cfm Normal Intake

-500+10 cfm Unfiltered Inleakage

- CR Exhaust

22

End of Plant Model FileScenario Description Name:

Plant Model Filename:

Source Term:11 1.OOOOE+00

C:\Program Files\radtrad3.03\EC-RADN-1128 R1 RADTRAD\SLBPhase 2.inpC:\Program Files\radtrad3.03\EC-RADN-1128_RIRADTRAD\SLB.RFT

0.OOOOE+0019.5000E-01 4.8500E-02 1.5000E-03 1.OOOOE+00

Overlying Pool:0o.OOOOE+00000

Compartments:3



--Compartment 3:11

ý0.0


00000

Pathways:4

Pathway 1:0000013o . 000E+003 .3300E-027. 2000E+0200000

Pathway 2:0000013o .OOOOE+006 .6600E-027. 2000E+02000000

Pathway 3:0000013o .OOOOE+006. 6600E-027 .2000E+0200000*0

Pathway 4:

0000013

2.2000E+06o.OOOOE+00o.OOOOE+00


o .OOOOE+O0o0.0006E+00o .OOOOE+0O

O.OOOOE+O0

O.OOOOE+00

O.OOOOE+00

6.3910E+036.3910E+03o.OOOOE+00

5. 1000E+025. 1000E+02o.OOOOE+00




0.OOOOE+001.OOOOE+02o.OOOOE+00



EC-RADN-. 128 Attachment 6 Page 65

o.0000E+005. 0000E-017.2000E+0200000

6. 9010E+036. 9010E+030.OOOOE+00

O. 0000E+00o.0000E+00o.0OOOE+00

o.O000E+00o.OOOOE+00o.OOOOE+00

o.0000E+00o.OOOOE+00o.0000E+00

0Dose Locations:

3Location 1:EAB -MST Release

213o.OOOOE+002.OOOOE+007.2000E+021

4o.OOOOE+008.OOOOE+002.4000E+017.2000E+020

Location 2:MSLB @ LPZ -

21

.5o.OOOOE+008.OOOOE+002.4000E+019.6000E+017.2000E+02

8.3000E-048.3000E-04o.OOOOE+00

3.5000E-041.8000E-042.3000E-040.OOOOE+00

MST Release

4.0.0000E+008.OOOOE+002.4000E+017.2000E+020

Location 3:MSLB @ CR - TB

30120.OOOOE+007.2000E+0214

4.9000E-053.5000E-051.7000E-056. 10OOE-060.OOOOE+00

3.5000E-041.8000E-042.3000E-040.OOOOE+00

MST Release

3.4700E-040.OOOOE+00

0.OOOOE+00 1.OOOOE+002.4000E+01 6.OOOOE-019.6000E+01 4.OOOOE-017.2000E+02 0.OOOOE+00

Effective Volume Location:1.3

0.OOOOE+00 6.300OOE-046.6600E-02 0.OOOOE+007.2000E+02 0.OOOOE+00

Simulation Parameters:40.OOOOE+00 1.OOODE-04

EC-RADN-1128 Attachment 6 Page 66

1.0000E-02 .4OOO0E-031.0000E-O1 1.OOOOE-027.2000E+02 o.oooOE+00

Output Filename:C:\Program Files\radtrad3.o7

11101

End of Scenario File


#######################################################################

RADTRAD Version 3.03 (Spring 2001) run on 10/24/2006 at 13:01:07###########4############################################################

########################################4###############################

Plant Description################################### ####################################

Number of Nuclides = 16

Inventory Power = 1.OOOOE+00 MWthPlant Power Level = 1.OOOOE+00 MWth

Number of compartments 3

Compartment information

Compartment number 1 (source term fraction = 1.OOOOE+00

Name: SSES MS TunnelCompartment volume = 4.4000E+04 (Cubic feet)Compartment type is NormalPathways into and out of compartment 1

Exit Pathway Number 1: SSESMST to Environs

Compartment number 2Name: EnvironmentCompartment.type is EnvironmentPathways into and out of compartment 2

Inlet Pathway Number 1: SSES MST to EnvironsInlet Pathway Number 4: SSES CR to Environment - CR ExhaustExit Pathway Number 2: Environment to SSES CR - 6391 cfm Normal IntakeExit Pathway Number 3: Environment to SSES CR -500+10 cfm Unfiltered Inle

Compartment number 3Name: SSES CRCompartment volume = 5.1800E+05 (Cubic feet)Compartment type is Control RoomPathways into and out of compartment 3

Inlet Pathway Number 2: Environment to SSES CR - 6391 cfm Normal IntakeInlet Pathway Number 3: Environment to SSES CR -500+10 cfm Unfiltered InleExit Pathway Number 4: SSES CR to Environment - CR Exhaust

Total number of pathways = 4


#########################################################4##############RADTRAD Version 3.03 (Spring 2001) run on 10/24/2006 at 13:01:07

###################################################4####################

#######################################################################Scenario Description

######################################################4#################

Radioactive Decay is enabledCalculation of Daughters is enabled

Release Fractions and TimingsGAP EARLY IN-VESSEL

0.000000 hr 0.0000.hrsNOBLES 1.OOOOE+00 . 0.OOOOE+00IODINE 1.OOOOE+00 0.OOOOE+00CESIUM 0.OOOOE+00 0.OOOOE+00TELLURIUM 0.OOOOE+00 0.OOOOE+00STRONTIUM 0.OOOOE+00 0.0000E+00BARIUM 0.OOOOE+00 0.OOOOE+00RUTHENIUM 0.OOOOE+00 0.OOOOE+00CERIUM 0.OOOOE+00 0.OOOOE+00LANTHANUM 0.ooo0E+00 0.OOOOE+00

LATE RELEASE0.0000 hrs0.OOOOE+000.OOOOE+000.0000E+000.OOOOE+000.OOOOE+000.OOOOE+000 .0000E+00

0.OOOOE+000.OOOOE+00

RELEASE MASS(gm)

1.322E-054.473E-050. OOOE+000.OOOE+000. OOOE+000. 000E+00

0. OOOE+000.OOOE+000. OOOE+00

Inventory Power = 1. MWt

NuclideName

1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe -135.Kr-83mKr-85mKr-87Kr-88Kr-85Xe-138

Nuclide1-1311-1331-135Xe-133mXe-135mXe-135Kr-85mKr-87Kr-88Xe-138

Group SpecificInventory

(Ci/MWt)2 2.400E+002 2.210E+012 1.640E+012 4.420E+012 2.400E+011 1.810E-031 3.390E-021 9.890E-011 3.150E+001 2.750E+001 4.190E-011 7.290E-011 2.360E+001 2.450E+001 2.430E-031 1.100E+01

halflife(s)

6 956E+058.390E+037. 533E+043. 150E+032 .423E+04

1. 036E+061. 987E+054 . 553E+059.360E+023 .287E+046. 840E+031.570E+044.680E+039. 972E+033 . 383E+088.490E+02

Whole BodyDCF

(Sv-m3/Bq-s)1.820E-141.120E-132.940E-141.300E-138.294E-143.378E-161.370E-151.560E-152.040E-141.190E-141.500E-187.480E-154.120E-141.020E-131.190E-165.770E-14

InhaledThyroid(Sv/Bq)

2. 920E-071. 740E-094. 860E-082. 880E-I08 .460E-090. OOOE+000 OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+000. OOOE+00

InhaledEffective

(Sv/Bq)8. 890E-091. 030E-101. 580E-093 .550E-113 .320E-100 OOOE+000 OOOE+000 .OOOE+00

0. OOOE+000 OOOE+000 .OOOE+00

0.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+00

DaughterXe-131mXe-133mXe-135mXe-133Xe-135Cs-135Kr-85Rb-87Rb-88

Cs-138

Fraction0.010.030.151.001.001.000.211..001.001.00

9. 5000E-014.8500E-021.5000E-03

DaughternoneXe-133Xe-135noneCs-135nonenonenonenonenone

Fraction0.000.970.850.000.000.000.000.000.000.00

Daughter Fractionnone 0.00none 0.00none 0.00none 0.00none 0.00none 0.00none 0.00none 0.00none 0.00none 0.00

Iodine fractionsAerosolElementalOrganic

COMPARTMENT DATA

EC-RADN-1128

Compartment number 1: SSES MS Tunnel

Compartment number 2: Environment

Compartment number 3: SSES CR

PATHWAY DATA

Pathway number 1: SSES MST to Environs



Time (hr)

0 0000E+003.3300E-027.2000E+02

Flow Rate(cfm)

2.2000E+06o.OOOOE+00o.0000E+00


0.0000E+00 0.OOOOE+00 0.0000E+000.0000E+00 0.0OOOE+00 0.0000E+000.0000E+00 0.0000E+00 0.0000E+00

Pathway number 2: Environment to SSES CR - 6391 cfm Normal Intake


Time (hr)

0.0000E+006.6600E-027.2000E+02

Flow Rate(cfm)

6.3910E+036.3910E+030.0000E+00


0.0000E+00 0.0000E+00 0.OOOOE+000.0000E+00 1.0000E+02 1.0000E+020.0000E+00 0.0000E+00 0.0000E+00

Pathway number 3: Environment to SSES CR -500+10 cfm Unfiltered Inle


Time (hr)

0.0000E+006.6600E-027.2000E+02

Flow Rate(cfm)

5. 1000E+025.1000E+020.OOOOE+00


0.0000E+00 0.0000E+00 0.OOOOE+000.OOOOE+00 1.OOOOE+02 1.0000E+020.OOOOE+00 0.0000E+00 0.OOOOE+00

Pathway number 4: SSES CR to Environment - CR Exhaust


Time (hr)

0.0000E+005.0000E-017.2000E+02

LOCATION DATALocation EAB

Flow Rate(cfm)

6. 9010E+036. 9010E+030.OOOOE+00

- MST Release


0.OOOOE+00 0.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+00 0.OOOOE+000.0000E+00 0.OOOOE+00 0.OOOOE+00

is in.compartment 2

Location X/Q DataTime (hr)

0.00OOE±002.OOOOE+007.2000E+02

X/Q (s * m'-3)8.3000E-048.3000E-040.OOOOE+00


0.OOOOE+008.0000E+002.4000E+017.2000E+02

Location MSLB @ LPZ - MST Rel

Rate (m'3 * sec^-l)3.5000E-041.8000E-042.3000E-040.OOOOE+00

.ease is in compartment 2

Location X/Q Data


Time (hr)0.0000E+008.OOOOE+002 .4000E+019.6000E+017.2000E+02

X/Q (s * m'-3)4.9000E-053.5000E-051.7000E-05

*6.1000E-06

o.OOOOE+00


0.OOOOE+008.OOOOE+002.4000E+017.2000E+02

Location MSLB @ CR - TB MST

Rate (mW3 * sec'-1)3.5000E-041.8000E-042.3000E-040.0000E+00

Release is in co mpartment 3

Location X/Q DataTime (hr)0.OOOOE+006.6600E-027.2000E+02

Location BreathingTime (hr)o.OOOOE+007.2000E+02

Location OccupancyTime (hr)

o.0000E+002.4000E+019. 6000E+017.2000E+02

X/Q (s * m'-3)6.3000E-04o.0000E+000.0000E+00

Rate DataBreathing Rate (mW3 * sec"-1)

3.4700E-04.0.0000E+00

Factor DataOccupancy Factor

1.0000E+006.0000E-014.0000E-010.0000E+00

USER SPECIFIED TIME STEP DATA - SUPPLEMENTAL TIME STEPSTime

0.0000E+001.0000E-021.0000E-017.2000E+02

Time step1.0000E-041.OOOOE-031.0000E-020.OOOOE+00


###########################################44##############################RADTRAD Version 3.03 (Spring 2001) run on 10/24/2006 at 13:01:07

#######################################################################

#4#4#4#444

# #4* #4#

#t ## #.#4#

#### ####4

* t##### ##### *4 # 4 #4#4 t 4 44#It * 4*4## #* * 4 *4 It 4 #

# I #

It #####* #* 4.It *# ItIt It

#4###################################################################Dose, Detailed model and Detailed Inventory Output

####################################################################




Whole Body8.3209E-068.3209E-06



MSLB @ CR- TB MST Release Doses:


Thyroid4.3156E-044.3156E-04

Thyroid2.5478E-052.5478E-05

Thyroid1.9833E-111.9833E-11

'SSES MS Tunnel Compartment Nuclide Inventory:

TEDE2.2869E-052.2869E-05

TEDE1.3501E-061.3501E-06

TEDE6.9666E-136. 9666E-13

Atoms8.9094E+169. 8953E+156. 5931E+167 .4304E+153 1036E+161. 0007E+143 .5949E+142 .4033E+161. 5735E+144. 8237E+151. 5295E+146. 1065E+145. 8943E+141.3039E+154.3871E+164. 9840E+14


0.0000 Ci2.3995E+002.2095E+011.6396E+014.4190E+012.3994E+011.8096E-033.3892E-029. 8877E-013. 1493E+002.7494E+004..1890E-017.2883E-012.3595E+002.4494E+002.4294E-031.0997E+01

kg1.9381E-082. 1690E-091 .4561E-081. 6533E-096. 9573E-092. 1769E-117. 9393E-115. 3077E-093. 5273E-111. 0813E-092. 1080E-118. 6191E-118. 5154E-111. 9053E-10.6. 1923E-091. 1421E-10

Decay4.8836E+074.4970E+083 .3371E+088.9939E+084.8836E+083.6830E+046.8981E+052 . 0124E+076.4097E+075.5958E+078.5259E+061.4834E+074.8022E+074.9853E+074.9447E+042.2383E+08

SSES MS Tunnel Transport Group Inventory:Time (h) = 0.0000 Atmosphere SumpNoble gases (atoms) 7.6500E+16 '0.00ýE+00Elemental I (atoms) 9.8642E+15 O.OOOOE+00


Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

3.0508E+14 0.OOOOE+004.2485E-08 0.000.OE+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

4.8147E-098.2902E-091.0907E+02



PathwayFiltered

0.OOOOE+000.OOOOE+000.0000E+000.OOOOE+00




0.0000 Ci1.1285E-061.0392E-057 .7115E-062 0783E-051. 1285E-058 .5109E-101. 5940E-084 .6504E-071 .4812E-061 .2931E-061. 9702E-073 .4279E-071 .1097E-061.1520E-061.1426E-095.1723E-06

kg9. 1151E-151. 0201E-156. 8483E-157. 7760E-163 .2722E-151. 0238E-173.7340E-172.4963E-151.6590E-175. 0858E-169. 9144E-184.0537E-174. 0050E-178. 9612E-172. 9124E-155.3715E-17

Atoms.4. 1903E+104.6540E+093. 1009E+103.4946E+091.4597E+104.7066E+071.6907E+081.1303E+107.4004E+072.2687E+097. 1935E+072.8720E+082.7722E+086.1325E+082. 0634E+102.3441E+08

Decay2.2969E+012.1150E+021.5695E+024.2300E+022.2969E+021.7322E-023 .2443E-019.4650E+003.0146E+012.6318E+014.0099E+006.9767E+002.2586E+012.3447E+012.3256E-021.0527E+02

'SSES CR Transport Group Inventory:Time (h) = 0.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)


1.9235E-163.3119E-165.1300E-05



PathwayFiltered





Aerosols (kg)

.Pathway

Filtered0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00


SSES CR to Environment - CR Exhaust Transport -Group Inventory:

Pathway

EC-RADN-1 128



Filtered1.4648E+031.8888E+025.8417E+008. 1352E-22




0.0333


Whole Body3.6295E-023.6303E-02



MSLB.@ CR - TB MST Release Doses:

Thyroid1.8828E+001.8832E+00

Thyroid1. 1I15E-011.1118E-01

Thyroid3.6830E-023.6830E-02

TEDE9. 9761E-029.9784E-02

TEDE5.8895E-035.8909E-03

TEDE1.2927E-031.2927E-03

Time.(h) = 0.0333Delta dose (rem)Accumulated dose (rem)

Whole Body5. 1646E-05S. 1646E-05

SSES MS Tunnel Compartment Nuclide Inventory:


SSES MS Tunnel Transport Group Inventory:Time (h) = 0.0333 Atmosphere SumpNoble gases (atoms) 3.1503E-27 0.OOOOE+00Elemental I (atoms) 4.0477E-28 0.OOOOE+00Organic I (atoms) 1.2519E-29 0.OOOOE+00Aerosols (kg) 1.7433E-51 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

1.9777E-523.3969E-524.4260E-42



PathwayFiltered




Time (h)1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83mKr-.85mKr-87Kr-88

0.0333 Ci4. 7958E-034. 3731E-023 .2739E-028. 6034E-024. 7800E-023. 6212E-066. 8118E-051. 9820E-036. 3712E-035 .6007E-038 .2726E-041 .4492E-034. 6334E-034 .85'57E-03

kg3. 8736E-114. 2929E-122. 9074E-113 .2189E-121. 3860E-114. 3562E-141. 5957E-131. 0639E-117. 1360E-142 .2028E-124. 1629E-141. 7138E-131. 6722E-133. 7771E-13

Atoms1.7807E+141. 9585E+131.3165E+141.4466E+136.1826E+132 . 0026E+117.2250E+114.8173E+133.1833E+119.8264E+123.0205E+111.2142E+121. 1575E+122.5848E+12

Decay2. 1365E+101. 9577E+111.4592E+113.8833E+112.1330E+111.6123E+073 . 0261E+088.8167E+092.8186E+102.4711E+103.7076E+096.4729E+092. 0824E+102.1721E+10


Kr-85Xe-138

4.8564E-061.9934E-02

1.2378E-112. 0701E-13

8.7698E+13 2.1634E+079.0338E+11 9.3271E+10


Atmosphere Sump1.5310E+14 0.0000E+001.9671E+13 0.OOOOE+006.0840E+11 0.OOOOE+008.4723E-11 0.00O0E+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

8. 1641E-131.4023E-122. 1510E-01



PathwayFiltered





PathwayFiltered


Transported1.1603E+13

1.4961E+124.6271E+106.4437E-12



PathwayFiltered

4.0856E+125.2590E+111.6265E+102.2650E-12




0.0666







Thyroid0.OOOOE+001.1118E-01

Thyroid3.6184E-027. 3014E-02



TEDE1.2683E-032.5610E-03

MSLB @ CR - TB MST Release Doses:




SSES MS Tunnel Transport Group Inventory:Time (h) = 0.0666 Atmosphere Sump


Noble gases (atoms),Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (.Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

3.1542E-27 0.OOOOE+004.0383E-28 0*0000E+001.2489E-29 0.0000E+001.7392E-51 0.OOOOE+001-131 (Thyroid).1-131 (ICRP2 Thyroid)

1.9750E-523 .3841E-524.3669E-42



PathwayFiltered

0.0000E+000.OOOOE+000.OOOOE+000.0000E+00



Time (h) =1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83mKr-85mKr-87Kr-88Kr-85Xe-138

0.0666 Ci4.6693E-034.2163E-023.1844E-028.1593E-024.6385E-023.5299E-066.6687E-051.9352E-036.2696E-035.5553E-037.9580E-041.4037E-034.4323E-034.6889E-034.7289E-061.7600E-02

kg3 .7714E-11

4. 1390E-122. 8280E-113 .0528E-121 .3449E-114 .2464E-141 .5622E-131. 0388E-117 .0223E-142 .1849E-124 .0046E-141 .6600E-131 .5996E-133 .6474E-131 .2053E-111. 8278E-13

Atoms1. 7337E+141. 8883E+131. 2805E+141. 3719E+i35. 9996E+131. 9521E+117. 0733E+114. 7036E+133 .1325E+11

9. 7467E+122. 9056E+111. 1761E+121. 1073E+122 .4960E+128. 5396E+137..9764E+II

Decay4.2347E+103 .8617E+11

2. 8909E+117.5986E+114.2208E+113.1975E+07.6.0142E+081.7500E+105. 6171E+104. 9436E+107.3053E+091.2797E+104. 0919E+104 .2878E+104.2882E+071.7637E+11

SSES CR Transport Group Inventory:Time (h) = 0.0666 Atmosphere SumpNoble gases (atoms) 1.4926E+14 0.OOOOE+00Elemental I (atoms) 1.9110E+13 0.OOOOE+00Organic I (atoms) 5.9103E+11 0.OOOOE+00Aerosols (kg) 8.2303E-II 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid).Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

7. 9389E-131.3603E-122. 0665E-01



PathwayFiltered





PathwayFiltered

0.OOOOE+000'.OOOOE+000.OOOOE+000.OOOOE+00

Transported1.1603E+131.4961E+124.6271E+106 .4437E-12




PathwayFiltered

8.1095E+121.0420E+123.2228E+104.4879E-12




0.5000








Thyroid3 .8940E-014.6241E-01

. TEDE

0.OOOOE+009.9784E-02


TEDE1.3537E-021.6098E-02



Whole Body4.7893E-045.8036E-04



SSES MS Tunnel Transport Group Inventory:Time (h) = 0.5000 Atmosphere SumpNoble gases (atoms) 3.2135E-27 0.OOOOE+00Elemental I (atoms) 3.9257E-28 0.OOOOE+00Organic I (atoms) 1.2141E-29 0.OOOOE+00Aerosols (kg) 1.6903E-51 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) .1-131 (ICRP2 Thyroid)Total I (Ci)

1.9419E-523..2338E-523.7056E-42



PathwayFiltered




Time (h)1-1311-1321-1331-1341-135Xe-131mXe-133mXe-133Xe-135mXe-135Kr-83mKr-85m

= 0.5000 Ci3.2970E-032..6212E-022.2199E-024.0935E-023.1372E-022.5316E-065.0425E-051.4169E-034. 7215E-034.8322E-034.8049E-049.2660E-04

kg2.6630E-112.5731E-121.9714E-111.5316E-129.0963E-123.0455E-141 1812E-137.6059E-125.2883E-141.9005E-122.4179E-141.0958E-13

Atoms1. 2242E+141.1739E+138.9265E+136. 8830E+124.0577E+131.4000E+115.3484E+113 .4439E+132 .3590E+118.4780E+121. 7543E+117.7,635E+11

Decay2. 6916E+112. 3164E+121. 8267E+124. 1504E+122 6302E+122. 0468E+083 .9467E+09

1. 1310E+113. 6933E+113 .4833E+11

4 .3251E+107. 8866E+10

EC-RADN-1 128 Attachment 6

6.2150E+111.5838E+126. 0404E+131.5781E+11

Page 77

Kr-87Kr-88Kr-85Xe-138

2.4878E-032.9752E-033.3449E-063.4822E-03

8.9786E-142.3143E-138.5257E-123.6163E-14

2.3459E+112.5957E+112.7278E+086.7765E+11


Atmosphere Sump1.0755E+14 0.OOOOE+001.3138E+13 0.OOOOE+00

4.0633E+11 0.0000,+005.6568E-ll 0.OOOOE+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

5.5203E-139. 1928E-131.2401E-01


Time (h) = 0.5000Noble gases (atoms)Elemental I (atoms)Organic. I (atoms)Aerosols (kg)

PathwayFiltered

0.0000E+000.OOOOE+000.0oooE+000.OOOOE+00

Transported1.4540E+141. 8748E+135.7984E+I18.0748E-11


Time (h) = 0.5000Noble gases,(atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)

PathwayFiltered





PathwayFiltered

5.2177E+136.5634E+122.0299E+112.8264E-11

Transported0.OOOOE+00O.OOOOE+00O.OOOOE+00O.OOOOE+00



2.0000

Time (h).= 2.0000Delta dose (rem)Accumulated dose (rem)







Thyroid6.3730E-011.0997E+00


TEDE0.0000E+005.8909E-03

TEDE2. 1671E-023.7769E-02



Whole Body5.5960E-041.1400E-03


Time (h) = 2.,0000 Ci kg Atoms Decay


SSES MS Tunnel Transport Group Inventory:Time (h) = 2.0000 Atmosphere SumpNoble gases (atoms) 3.4347E-27 0.OOOOE+00Elemental I (atoms) 3.6387E-28 0.OOOOE+00Organic I (atoms) 1.1254E-29 0.OOOOE+00Aerosols (kg) 1.5656E-51 0.0000E+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

1.8433E-522.8729E-522.4065E-42



PathwayFiltered


Transported7.6489E+169.8625E+153. 0503E+144.2478E-08


Time (h) =


2.0000 Ci9.8868E-045.0585E-036.3684E-033.7611E-038. 1045E-037.9984E-071.8452E-054.7567E-041.2801E-032.2462E-038.3811E-052.2009E-043.3709E-046.1629E-041.0090E-061.2778E-05

kg.7.9857E-124.9657E-135.6556E-121.4072E-132.3499E-129.6219E-154.3225E-142.5534E-121.4338E-148.8347E-134.2176E-152.6028E-141.2166E-144.7940E-142.5719E-121.3270E-16

Atoms3.6711E+132.2655E+122.5608E+136.3241E+111.0483E+134 .4232E+101. 9572E+111. 1562E+136. 3960E+103 .9410E+123 0601E+101.8440E+118.4212E+103.2807E+111.8221E+135.7907E+08

Decay6.5057E+114.8751E+124.3496E+127.2491E+126.0511E+125.0380E+081.0298E+102. 8490E+118. 9427E+111. 0369E+128. 8456E+101.7667E+114.4871E+115.5774E+116.6066E+088.0076E+11


Atmosphere Sump3.4656E+13 0.0000E+003.6714E+12 0.0000E+001.1355E+11 0.0000E+001.5797E-11 0.0000E+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

1.5798E-132.4622E-132.4281E-02



PathwayFiltered

0.0000E+000.0000E+000.0000E+000.0000E+00




PathwayFiltered

0.0000E+000.0000E+000.0000E+000.-000OE+00





PathwayFiltered

1.2939E+141.5449E+134.7780E+116.6511E-11

Transported0.OOOOE+000.OOOOE+000.OOOOE+000.0000OE+00



8.0000






Thyroid0. OOOOE+001. 1118E-01

Thyroid2.5536E-011.3551E+00



TEDE8.4465E-034. 6215E-02


Whole Body1.2919E-041.2692E-03



SSES MS Tunnel Transport Group Inventory:Time (h) = 8.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

Atmosphere Sump4.0353E-27 0.0000E+003.0263E-28 0.OOOOE+00

9.3596E-30 0.OOOOE+001.2996E-51 0.OOOOE+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

1.5656E-522. 1936E-521.1337E-42



PathwayFiltered




Time (h) =

1-1311-1321-133.1-1341-135Xe-131mXe-133mXe-133xe-135mXe-135

8.0000 Ci7.9948E-067. 0164E-064 .3133E-052.6804E-073.6097E-057. 7891E-092.4171E-075.3059E-065.7076E-062.9738E-05

kg6.4575E-146. 8878E-163.8305E-141.0029E-171.0467E-149.3701E-175.6621E-162.8482E-146.3928E-171.1696E-14

Atoms2. 9685E+113.1424E+091. 7344E+114. 5071E+074.6690E+104.3075E+082.5638E+091.2896E+112 .8517E+085.2174E+10

Decay8.1260E+115 .4862E+125. 3576E+127. 5626E+127. 2374E+126. 4020E+081. 3724E+103. 6909E+111. 0794E+121 .4759E+12

EC-RADN-1 128

Kr-83mKr-85mKr-87Kr-88Kr-85

7.7585E-087.0055E-071.1363E-071.1346E-068.3474E-09

3 .9042E-188.2846E-174.1008E-188.8260E-172 .1276E-14

Attachment 6

2.8328E+075.8695E+082 8386E+076.0400E+081.5074E+1I

Page 80

9. 7999E+102.0705E+114.8226E+116.3550E+118.2680E+08



1.1086E-151.5533E-159.4510E-05



PathwayFiltered




Time (h) = 8.0000Noble gases (atoms)Elemental I. (atoms)Organic I (atoms)Aerosols (kg)

PathwayFiltered





PathwayFiltered

1.6524E+141.8936E+135.8564E+118.1509E-11





Whole Body0.OOOOE+00

3.6303E-02




Time (h) = 24.0000 Whole BodyDelta dose (rem) 4.2770E-07Accumulated .dose (rem) 1.2696E-03



Thyroid1.8200E-031.3569E+00



TEDE5.8519E-054.6274E-02




SSES MS Tunnel Transport Group Inventory:Time (h) = 24.0000 Atmosphere SumpNoble gases (atoms) 4.4915E-27 0.OOOOE+00Elemental I (atoms) .2.2771E-28 0.OOOOE+00Organic I (atoms) 7.0425E-30 0.OOOOE+00

Aerosols (kg) 9.7479E-52 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

1.1530E-521.4360E-524 . 7917E-43



Pathway.Filtered




Time.(h) = 24.00001-1311-1331-135Xe-133mXe-133Xe-135Kr-85

Ci2. 1061E-1I7. 0831E-111. 9386E-111. 0404E-122. 1212E-115 .4284E-112 .3303E-14

kg1. 7011E-196 .2903E-205. 6210E-212 .4371E-211. 1387E-192. 1350E-205. 9397E-20

Atoms7.8200E+052.8482E+052.5074E+041.1035E+045. 1558E+059.5240E+044.2082E+05

Decay8. 1393E+115.3645E+127.2427E+121.3767E+103. 7001E+111.4809E+128.2819E+08

SSES CR Transport Group Inventory:Time (h) = 24.0000 Atmosphere SumpNoble gases (atoms) 1.0446E+06 0.OOOOE+00Elemental I (atoms) 5.2960E+04 0.0060E+00Organic I (atoms) 1.6380E+03 0.OOOOE+00Aerosols (kg) 2.2672E-19 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

2.2779E-212.8370E-211.1145E-10



PathwayFiltered





PathwayFiltered

0.OOOOE+00O.OOOOE+000.OOOOE+000.0000E+00




PathwayFiltered

1.6558E+141.8960E+135.8640E+11

Transported0.OOOOE+000.OOOOE+000.OOOOE+O0

EC-RADN-1 128

Aerosols (kg)


8.1614E-11 0.OOOOE+00

Detailed model information at time. (H) = 96.0000







Thyroid0.OOOOE+001. 1118E-01

Thyroid2.2645E-091.3569E+00



TEDE7. 1085E-114.6274E-02



Whole Body2.2450E-131.2696E-03



SSES MS Tunnel Transport Group Inventory:Time (h) = 96.0000 Atmosphere SumpNoble gases. (atoms) 4.2196E-27 0.OOOOE+0Elemental I (atoms) 1.3142E-28 0.OOOOE+0Organic I (atoms) 4.0647E-30 0.OOOOE+0Aerosols (kg) 5.6034E-52 0.OOOOE+0Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)

0000

5.9882E-536.2154E-539.8035E-44Total I (Ci)



PathwayFiltered





SSES CR Transport Group Inventory:Time (h) = 96.0000 Atmosphere SumpNoble gases (atoms) 9.9314E-20 0.OOOOE+00Elemental I (atoms) 3.0932E-21 0.OOOOE+00Organic I (atoms) 9.5666E-23 0.OOOOE+00Aerosols (kg) 1.3188E-44 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

1. 1972E-461.2426E-462.3074E-36



PathwayFiltered


Transported1.4540E+141.8748E+135.7984E+11

EC-RADN- 1128

Aerosols (kg)


0.00-OOE+00 8..0748E-11



PathwayFiltered.





PathwayFiltered

1.6558E+141.8960E+135.8640E+118.1614E-11











Thyroid8.0315E-351.3569E+00

TEDE0.OOOOE+009..9784E-02


TEDE2.4570E-364.6274E-02





SSES MS Tunnel Transport Group Inventory:Time (h) = 720.0000 Atmosphere SumpNoble gases (atoms) 1.8971E-27 0.OOOOE+00Elemental I (atoms) 1.3429E-29 0.OOOOE+00Organic I (atoms) 4.1533E-31 0.OOOOE+00Aerosols (kg) 5.7220E-53 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid)Total I (Ci)

5. 9851E-545. 9851E-547.4570E-45


Time (h) = 720.0000Noble gases (atoms)Elemental I *(atoms)Organic I (atoms)Aerosols (kg)

PathwayFiltered


Transported7.6489E+16.9.8625E+153.0503E+144.2478E-08

'SSES CR Compartment Nuclide Inventory:

Time (h) = 720.4DOOO Ci kg Atoms Decay



Atmosphere Sump1.0663-236 0.OOOOE+007.5483-239 0.00OOE+002.3345-240 0.0000E+003.2163-262 0.0000E+001-131 (Thyroid)1-131 (ICRP2 Thyroid)

2.8576-2642.8576-2644.1915-254



PathwayFiltered


Transported1.4540E+141.8748E+135. 7984E+118.0748E-II



.PathwayFiltered.





PathwayFiltered

1.6558E+141.8960E+135.8640E+118.1614E-11

Transported0..OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

72185

####################################################################1-131 Summary

####################################################################

Time (hr)0.0000 .0330 .0670.3300 .5000.7501.0001.2501.5001.7502.0002.2502.5002.7503.0003.2503.5003.7504.0004.250

SSES MS Tunnel1-131 (Curies)

2.3995E+009. 8681E-449. 8670E-449. 8577E-449. 8516E-449. 8428E-449.8340E-449. 8252E-449. 8164E-449. 8076E-449. 7988E-449.7900E-449.7812E-449.7724E-449.7637E-449.7549E-449.7462E-449.7375E-449.7287E-449.7200E-44

. Environment1-131 (Curies)

5.50OOE-042.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002 .4000E+00

2 .4000E+002 .4000E+002 .4000E+002 .4000E+002. 4000E+002 .4000E+002.4000E+002.4000E+002 .4000E+002,.4000E+002.4-00E+002.4000E+00.2.4000E+00

SSES CR1-131 (Curies)

1. 1285E-064. 7958E-034. 6693E-033. 7792E-033 .2970E-032. 6974E-032 .2068E-031. 8055E-031 .4771E-031. 2085E-039.8868E-048. 0887E-04.6. 6176E-04.5 .4141E-044 .4294E-043. 6239E-042. 9648E-042 .4256E-041. 9844E-041 .6235E-04


4.5004.7505.0005.2505.5005.7506 .0006.2506.5006.7507.0007.2507.5007.7508 .0008.2508.5008 .7509.0009.2509.5009.7500 .000

10.25024 .00096.000

720.000

9. 7113E-449.7026E-449.6939E-449.6852E-449.6765E-449.6678E-449.6592E-449.6505E-449. 6419E-449.6332E-449. 6246E-449. 6160E-449.6073E-449. 5987E-449. 5901E-449. 5815E-449.5729E-449.5644E-449.5558E-449. 5472E-449.5387E-449. 5301E-449. 5216E-449. 5130E-449.0552E-446.9940E-447.4570E-45

2.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4'000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+002.4000E+00

2.4000E+002.4000E+002.4000E+00

1.3283E-041.0867E-048.8906E-057.2737E-055.9508E-054.8685E-053. 9831E-053.2587E-052.6660E-052. 1812E-051.7845E-051.4599E-051.1944E-059.7720E-067.9948E-066 .5408E-06

5.3512E-064.3780E-063.5818E-062.9304E-062.3974E-061. 9614E-061.6047E-061.3128E-062 .1061E-111.6461E-364.1915-254

####################################################################Cumulative Dose Summary

####################################################################

EAB - MST Re

Time Thyroid(hr)0.0000.0330.0670.3300.5000.7501.0001.2501.5001.7502.0002.2502.5002.7503 .0003.2503 .5003 .7504.0004.2504 .5004 .7505.0005.2505.5005.7506.0006 .2506 .5006 .7507.000

(rem)0.0000E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001. 8832E+001. 8832E+001. 8832E+001. 8832E+001. 8832E+001.8832E+001.8832E+001.8832E+001.8832E+001. 8832E+001. 8832E+001. 8832E+001. 8832E+001.8832E+001.8832E+001.8832E+001.8832E+001. 8832E+001. 8832E+001. 8832E+001. 8832E+001. 8832E+001.8832E+001.8832E+001.8832E+00

0.09.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.99.9

lease MSLB @ LPZTEDE Thyroid(rem) (rem)000E+00 0.0000E+00784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784E-02 1.1118E-01784,E-02 1.1118E-01784E-02 1.1118E-01

- MST ReleTEDE(rem)

0.0000E+005.8909E-035.8909E-035.8909E-035. 8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-03

MSLB @ CR - TB MST ReThyroid TEDE

(rem) (rem)0.0000E+00 0.0000E+003.6830E-02 1.2927E-037.3014E-02 2.5610E-033.2627E-01 1.1389E-024.6241E-01 1.6098E-026.3052E-01 2.1876E-027.6691E-01 2.6533E-028.7761E-01 3.0292E-029.6748E-01 3.3328E-021.0404E+00 3.5783E-021.0997E+00 3.7769E-021.1478E+00 3.9376E-021.1870E+00 4.0678E-021.2187E+00 4.1733E-021.2446E+00 4.2588E-021.2655E+00 4.3281E-021.2826E+00 4.3844E-021.2965E+00 4.4300E-021.3077E+00 4.4671E-021.3169E+00 4.4971E-021.3244E+00 4.5215E-021.3304E+00 4.5414E-021.3354E+00 4.5575E-021.3394E+00 4.5705E-021.3426E+00 4.5812E-021.3453E+00 4.5898E-021.3474E+00 4.5968E-021.3492E+00 4.6025E-021.3506E+00 4.6072E-021.3518E+00 4.6109E-021.3527E+00 4.6140E-02


7.2507.5007.7508.0008.2508.5008.7509.0009.2509.500

.9.75010.00010.25024.00096.000

720.000

1.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E+001.8832E-001.8832E+001.8832E+00

9.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-029.9784E-02

1.1118E-011.1118E-011. 1118E-011.1118E-011. 1118E-'011.1118E-011.1118E-011.1l18E-011.1118E-011.1118E-011.1118E-011.1118E-011.1118E-011.1118E-011.1118E-011.1118E-01

5.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-035.8909E-03

1.3535E+001.3541E+001.3547E+001.3551E+001.3554E+001.3557E+001.3559E+001.3561E+001.3562E+001.3564E+001.3565E+001.3565E+001.3566E+001.3569E+001.3569E+001.3569E+00

4.6165E-024.6185E-024.6202E-024.6215E-024.6226E-024.'6235E-024.6242E-024.6248E-024.6253E-024.6257E-024.6260E-024.6262E-024.6264E-024.6274E-024.6274E-024.6274E-02

############################################################W#######Worst Two-Hour Doses

####################################################################

EAB - MSTTime(hr)

0.0

ReleaseWhole Body

(rem)3.6303E-02

Thyroid(rem)

1.8832E+00

TEDE(rem)

9.9784E-02

Attachment 2 to PLA-6124

PPL Drawings E-105004, Sheets 3 and 6

THIS PAGE IS ANOVERSIZED DRAWING OR

FIGURE,THAT CAN BE VIEWED AT THE

RECORD TITLED:DRAWING-NO. E105004, SHEET NO. 3

REV. 26, GENERAL FLOOR PLANSELS 683-0,699-0,714-0 & 716-3"

WITHIN THIS PACKAGE...

D-01

THIS PAGE IS ANOVERSIZED DRAWING OR

FIGURE,THAT CAN BE VIEWED AT THE

RECORD TITLED:DRAWING NO. E105004, SHEET NO. 6

REV. 23, SUSQUEHANNA S.E.S.UNIT 1/ UNIT 2, GENERAL FLOOR

PLANEL'S 779'-1", 799'-1" & 806'-0"

WITHIN THIS PACKAGE... OR

D-02